Identification of immune correlates of natural protection against tuberculosis in a population with a high incidence of latent infection by Golakai, Hawa Jande
  - i -
Identification of Immune Correlates of 
Natural Protection against Tuberculosis in 
a population with a high incidence of Latent 
Infection 
 
 
                      Hawa Jande Golakai 
 
 
 
Thesis presented in partial fulfilment for the degree of Master of Science 
at           
                                  the University of Stellenbosch 
 
 
 
                               Promoter: Professor Gerhard Walzl 
                                  Co-promoter: Dr Gillian Black 
 
                            
                                                  March 2008 
 
  - ii -
Declaration 
I, the undersigned, hereby declare that the work contained in this dissertation is my 
own original work and that I have not previously in its entirety or in part submitted it 
at any university for a degree. 
 
Signature: …………………………………   Date: ………………………….. 
 
Hawa Jande Golakai (student number 14976293) 
 
Copyright ©2008 Stellenbosch University 
All rights reserved 
 
http://scholar.sun.ac.za/
  - iii -
 
Summary 
Setting 
This study was conducted in the Tygerberg area of Cape Town in South Africa. 
 
Background 
A third of the world’s population is latently infected with Mycobacterium tuberculosis, 
and correlates of protection against progression to active disease urgently need to be 
identified to facilitate the development of an effective vaccine against the disease. The 
production of IFN-γ is recognised as an immune correlate of protection from tuberculosis, 
but other immune regulators have been implicated in playing a significant role in 
protective immunity. The aims of this project were three-fold: (i) to identify promising 
TB vaccine candidates by screening a panel of novel MTB antigens, by stimulating whole 
blood cultures in vitro with the novel proteins and quantifying the level of IFN-γ 
production, (ii) to identify other cytokines and chemokines that may be immune 
correlates of protection using the Luminex fluorescent bead-based technique and (iii) to 
compare the performance of the two techniques.  
 
Methods 
Antigen Screening study 
Whole blood of 57 adult and adolescent participants defined as latently infected 
individuals was stimulated with a panel of 78 novel TB-specific, DosR- or RD1-encoded 
antigens. The 7-day culture supernatants were used in IFN-γ ELISA to quantify the level 
of IFN-γ production. 
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Luminex Assay study 
Whole blood culture supernatants of 15 HIV negative, TST positive adults were used in 
the Luminex LINCO 21-plex cytokine assay. This was done to determine which of 21 
cytokines, that may be LTBI-associated cytokines, were produced after stimulation with 9 
TB-specific recombinant antigens, and to quantify their level of expression.  
 
Results 
In the antigen screening study, it was found the majority of the 78 proteins tested were 
able to induce a positive IFN-γ response. The classic TB antigens were used as controls, 
and the frequency of responses was highest after stimulation with ESAT-6 and 
TesatCFP10 (80 – 85% of responders). Ten latency antigens elicited an IFN-γ response in 
19 – 45% of participants, and five reactivation antigens stimulated a positive reaction in 
15 – 48% of responders. The category of antigens that elicited the most frequent and 
highest responses overall was the resuscitation-promoting factors (Rpf). Over 30% of 
participants responded to all 5 Rpfs, and the level of responses were equally divided in 
the low and moderate-to-high levels, with an additional 5% of responses in the high 
(>1000pg/ml) range. 
 
In the Luminex study, the positive stimulant TesatCFP10 consistently induced expression 
of most cytokines. In addition latency antigens Rv1733c, Rv0569 and Rv2029c also 
induced moderate-to-high level cytokine expression. A Th1-biased cytokine profile was 
observed, with the preferential expression of pro-inflammatory and cell-mediated 
cytokines like IFN-γ, TNF-α, IP-10, MIP1-α and G-CSF being produced. Th2 cytokines 
IL-4, IL-5, IL-13 and eotaxin were very poorly expressed or were not expressed at 
detectable levels. A very strong induction of IL-6, IL-8 and MCP-1 was observed, but this 
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cytokine/chemokine association suggested contamination of the recombinant antigens 
with bacterial endotoxins. 
 
Conclusion 
In this study of latently infected individuals, the pattern of response observed for both 
assays is largely a Th1-biased expression profile. The whole blood ELISA method is a 
well-established assay for quantifying IFN-γ in culture supernatants, and has proven to be 
effective here. This study has demonstrated, in humans with LTBI, immune recognition 
of these novel MTB-specific antigens as illustrated by the positive IFN-γ levels induced 
after stimulation. The multiplex technology is also a very versatile and sensitive assay, 
capable of detecting multiple analytes simultaneously in one sample. The multiplex has 
been valuable here in identifying some antigens as potential vaccine candidates, and a 
subset of cytokines as potential immune mediators and prognostic indicators in TB 
infection. 
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Opsomming 
Studie-area 
Hierdie studie was gedoen in die Tygerberg area van Kaapstad in Suid-Afrika. 
 
Agtergrond 
‘n Derde van die wêreld se bevolking is latent geïnfekteer met Mycobacterium 
tuberculosis en korrelate van beskerming teen die siekte moet geïdentifiseer word om 
die ontwikkeling van ‘n effektiewe enstof te fasiliteer.  Die produksie van IFN-γ is 
welbekend as ‘n immuunkorrelaat van beskerming teen tuberkulose (TB), maar ander 
immuunreguleerders speel ook ‘n belangrike rol in beskermende immuniteit.  Die 
doelwitte van hierdie projek was drievoudig: (i) om belowende TB-entstof kandidate 
te identifiseer deur die sifting van ‘n paneel van nuwe MTB antigene mbv die in vitro 
stimulasie van volbloed kulture, ii) om ander sitokiene en chemokiene as 
immuunkorrelate van beskerming te identifiseer deur van die Luminex fluorescent 
bead-based tegniek gebruik te maak, en (iii) om die twee tegnieke te vergelyk op 
grond van hul  prestasie as prognostiese of siftings metodes in latente infeksie. 
 
Metodes 
Antigeen siftings studie 
Volbloed van 57 volwasse en adolessente deelnemers, geïdentifiseer as latent 
geïnfekteerde individue, was gestimuleer met ‘n paneel van 78 nuwe TB-spesifieke 
DosR- or R-gekodeerde antigene.  Die 7-dae kultuur supernatante was gebruik in ‘n 
IFN-γ ELISA om die hoeveelheid IFN-γ produksie the kwantifiseer. 
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Luminex assay studie 
Volbloed kultuur supernatante van 15 HIV negatiewe, TST positiewe volwassenes 
was gebruik in die Luminex LINCO 21-plex cytokine assay.  Dit was gedoen om die 
tipes en hoeveelheid ander LTBI-geassosieerde sitokienes te identifiseer wat 
geproduseer word na stimulasie met 9 TB-spesifieke rekombinante antigene.  
 
Resultate 
In die antigeen siftings studie is gevind dat die meerderheid van die 78 getoetste 
proteïene ‘n positiewe IFN-γ reaksie kon induseer.  Vir die kontroles was die 
frekwensie van reaksies die hoogste na stimulasie met ESAT-6 en TesatCFP-10 (80 – 
85% van reageerders).  Tien latensie antigene was gereeld herken deur 19 – 45% van 
deelnemers en vyf reaktiverings-antigene het ‘n positiewe reaksie in 15 – 48% van 
reageerders gestimuleer.  Die kategorie van antigene wat die meeste en hoogste 
response veroorsaak het, was die resusitasie-promoterende faktors (Rpf).  Meer as 
30% van deelnemers het op al 5 Rpfs gereageer en die vlak van reaksies was gelyk 
verdeel in die lae en matig-tot-hoog vlakke, met ‘n addisionele 5% van reaksies in die 
hoë (>1000pg/ml) reeks. 
 
In die Luminex studie het die positiewe stimulant TesatCFP-10 konsekwent die 
positiewe uitdrukking van die meeste sitokiene geïnduseer.  Saam met dit het die 
latente antigene Rv1733c, Rv0569 en Rv2029c ook matige-toe-hoë vlakke van 
sitokien uitdrukking geïnduseer. ‘n Th1-gebaseerde sitokien profiel was waargeneem, 
met die begunstigde uitdrukking van pro-inflammatoriese en sel-gemedieerde 
sitokiene soos IFN-γ, TNF-α, IP-10, MIP1-α en G-CSF.  Th2 sitokiene IL-4, IL-5, IL-
13 en eotaksien was of baie sleg uitgedruk of onder naspeurbare vlakke uitgedruk.  ‘n 
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Baie sterk induksie van IL-6, IL-8 en MCP-1 was waargeneem, maar hierdie 
sitokiene/chemokiene assosiasie stel moontlik kontaminasie van die rekombinante 
antigene met bakteriële endotoksiene voor. 
 
Samevatting 
Die reaksiepatroon wat in hierdie studie tussen die twee toetse waargeneem is, was 
grootliks ‘n Th1-gebaseerde uitdrukkingsprofiel vir latente infeksie met TB.  Die 
volbloed ELISA metode is a betroubare gevestigde toets vir die kwantifisering van 
IFN-γ in kultuur supernatante, wat ook in hierdie studie bewys is om effektief te wees.  
Hierdie studie het gedemonstreer dat die nuwe TB-spesifieke antigene effektief 
positiewe IFN-γ response in mense met LTBI induseer.  Die multipleks tegnologie is 
ook ‘n baie veelsydige en sensitiewe toets, wat in staat is om veelvoudige analite 
gelyktydig in een monster te kan opspoor.   In hierdie studie was dit veral waardevol 
in die identifisering van ander moontlike antigene as prognostiese kandidate en 
sitokiene as immuunbemiddelaars in TB-infeksie. 
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                                       CHAPTER 1: Introduction                                          
1.1 Epidemiology of Tuberculosis 
Tuberculosis (TB) has long been and remains a serious health problem globally, 
especially in the resource-deficient developing world. A recent resurgence of the disease 
resulted in TB being declared a global health emergency by the World Health 
Organisation (WHO) in 1993. The convergence of the epidemic with the increasingly 
high incidence of HIV-1 infection worldwide has further compounded the problem, 
making the treatment and control of disease more difficult.  
 
 
 
Figure 1: Incidence Rates of Tuberculosis worldwide, as estimated by the WHO in 2005. 
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Death from dual TB-HIV infection is currently the leading cause of mortality worldwide, 
most strikingly in Sub-Saharan Africa. An estimated one-third of the world’s population 
is currently infected with the causative pathogen Mycobacterium tuberculosis (MTB), 
resulting in about 2 million deaths and a reported 9 to 10 million new cases annually 
(Dye C. et al., 2005). A recent projection by The Stop TB Department of the WHO has 
predicted that a reduction in the spread, prevalence and death rate can be achieved in 
most parts of the world by 2015, though the task will be most daunting in the worst-
affected areas of Africa and Eastern Europe (Dye C. et al., 2005). Discovery of a vaccine 
for the disease, the attenuated form of Mycobacterium bovis called Bacillus Calmette 
Guerin (BCG), provided hope of positive prospects for treatment and cure. In most 
countries worldwide, BCG vaccination at birth is and has been routinely practised, and an 
estimated 3 billion doses has been administered worldwide during the past four decades 
(Gupta U.D et al., 2007). The positive outlook in its effects was short-lived however, as 
the vaccine went to demonstrate highly variable efficacy in protecting adult subjects from 
pulmonary TB, the most common variety (Fine P.E, 1995). In addition, BCG has been 
particularly disappointing in providing reliable protection in the developing world, where 
unfortunately, TB is highly endemic.  
 
One of the most challenging aspects of controlling TB however, lies not only in effective 
treatment of active disease but in understanding latent infection. Of the 2 billion people 
currently infected, only 5-10% ever present with clinically active disease (Styblo K., 
1991). Most healthy persons are able to contain the pathogen for extended periods 
without actually eliminating the initial infection, a state of dormancy known as clinical 
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latency or latent infection. This population of asymptomatic individuals represents a 
massive reservoir of the bacillus that keeps perpetuating the spread of the disease. 
Ironically, they also clearly illustrate the importance of a potent immune response that is 
obviously required to prevent the disease from ever gaining headway. Beginning to 
understand why only a relatively small proportion of people progress to disease would 
provide insight into how the host immune system works to control TB. Elucidating the 
immune profile post-infection and defining what constitutes protective immunity would 
ultimately give rise to valuable tools in drug and vaccine therapy.  
 
1.2 MTB Infection and Immunity 
1.2.1 Early Phase Infection 
TB is transmitted via the aerosol route, when expelled droplets harbouring 
Mycobacterium tuberculosis bacilli are inhaled and begin the initial interaction in the 
lungs with alveolar macrophages. M. tuberculosis infects and replicates rapidly in the 
macrophages of the airways, quickly migrating to those of the lung parenchyma and also 
to differentiated monocytes that are recruited to the site (Algood H.M.S et al., 2003). The 
result is an activation of a cascade of inflammatory molecules that include the all-
important cytokine and chemokine mediators that regulate the course of infection. 
Circulating dendritic cells in the vicinity are also infected by MTB and consequently 
migrate to the lymph nodes to prime naïve T cells (Gonzalez-Juarrero M. et al., 2001). 
Subsequent lung inflammation is the signal that recruits effector T lymphocytes back to 
the region of infection, where a conglomeration of these cells forms a granuloma.  
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1.2.2 Granulomas: Composition and Function 
Granulomas typify MTB infection, and represent an attempt on the part of the host’s 
immune system to contain and repress the effects of the bacillus. Their formation is 
resultant of a highly activated cell mediated response, as they are composed of 
macrophages, CD4, CD8 and γδ T lymphocytes, as well as B lymphocytes. Granulomas 
function to physically contain infectious bacilli at the primary site of infection, thereby 
depriving them of oxygen and nutrients and limiting their spread to other regions. They 
also function to create a microenvironment for immune cross-talk between host cells, 
leading to continual macrophage activation, cytokine production and effective killing of 
bacteria by CD8 T lymphocytes (Algood H.M.S et al., 2003; Andersen P., 2007).  This 
effectively limits bacterial replication and localises inflammation to the infectious site. 
The structure of the granuloma comprises a macrophage-rich centre with surrounding 
lymphocytes that penetrate the core. This macrophage-lymphocyte aggregate begins to 
form 2-3 weeks post-infection, maturing into larger, more distinct bodies within 4-5 
weeks (Algood H.M.S et al., 2003). 
 
Granulomatous cavities containing live but dormant MTB can persist for decades, as 
significant numbers of bacteria can escape eradication by the cell-mediated response, 
giving rise to the state of latent infection. Therefore whilst initially beneficial, this 
attempt to contain the infection can result in subsequent immunopathology that is 
detrimental to the host. 
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1.2.3 Cell-mediated Immune (CMI) Response 
1.2.3.1 CD4 T Cells 
Components of the T-cell compartment form a highly essential part of protective 
immunity against an intracellular pathogen like M. tuberculosis. Since the primary 
residence of the bacteria is inside the phagosome of macrophages, their secreted peptide 
products are readily presented to CD4 T cells via the MHC II pathway. CD4 T cells are 
of the T-helper 1 type and are prime mediators of protection against TB. They typically 
produce IFN-γ, which, along with an array of other cytokines like TNF-α and interleukin-
2 (IL-2) that characterise the Th1 profile, activate macrophages (Flynn J.L and Chan J., 
2001). Activated macrophages initiate the production of effector molecules such as 
reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI), and 
begin the development of granulomas to isolate and control bacterial replication (Walker 
L. and Lowrie D.B, 1981; MacMicking J. et al., 1997). In addition to possessing 
antimycobacterial activity, macrophages can also kill intracellular invaders in some cases 
(Flesch I. et al., 1987; Chan J. et al, 1992). In murine studies, methods resulting in 
antibody depletion of CD4 cells (Muller I. et al., 1987), adoptive transfer (Orne I. and 
Collins F., 1984), or the use of knock-out mice (Caruso A.M et al., 1999) have provided 
results that show the CD4+ T cell subset to be vital for controlling infection. The 
production of IFN-γ and its synergistic effects with TNF-α, whilst important, is thought 
to be only one of the roles of CD4 T cells in tuberculosis infection, others remaining 
unclear or less prominent. In MHC II- and CD4-knockout mice where IFN-γ was 
severely depleted in early infection, the mice were still not rescued by a later surge in 
IFN-γ production within the CD8+ T cell subset, and succumbed to infection nevertheless 
http://scholar.sun.ac.za/
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(Caruso A.M et al., 1999). Other studies have shown that the protective response against 
tuberculosis does not wholly rely on the associated induction of nitric oxide synthase 
(NOS2) after IFN-γ production, and there may be more functions for CD4+ T cells 
(Scanga C.A et al., 2000).  Speculation as to how these T cells contribute to the immune 
response include helping to activate or mature antigen-presenting cells (APCs) (Campos-
Neto A. et al., 1998), priming and maintaining CD8+ effector and memory function 
(Kalams S.A et al, 1998), affecting the role of B cells in infection (Bosio C.M et al, 
2000), and inducing apoptosis or cell lysis (Keane J. et al, 1997). Clearly, CD4 T cell 
responses are an important facet of the host immune response after MTB infection. 
 
1.2.3.2 CD8 T cells 
The CD8+ T cell subset is also an important component during the course of infection 
with TB. In addition to also being potent producers of IFN-γ like CD4 cells, CD8 T cells 
are effective killer cells that are key mediators in acquired resistance against disease 
(Kaufmann S.H.E et al, 2006). They secrete perforin and granulysin that target and kill 
infected cells. Other roles for CD8 T cells have also been studied. Since M. tuberculosis 
classically resides in vacuoles and there are very few bacilli free in the cytosol, the 
mechanism of antigen presentation via the cytoplasmic MHC I route, which involves 
CD8+ T cells, was largely neglected for many years. More recently though, evidence for 
how mycobacterial antigens can be loaded and recognised via the MHC I route have been 
found. M. tuberculosis is a pathogen that induces apoptosis, resulting in the formation of 
vesicles containing proteins and glycolipids that get taken up by dendritic cells (DC). As 
the most efficient APCs of the immune system, dendritic cells then facilitate loading of 
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the vesicular contents, allowing stimulation of the associated MHC I and II T cell 
populations (Geijtenbeek T.B.H et al., 2003; Schaible U.E et al., 2003). CD1 loading, 
which represents an unconventional or MHC I-unrestricted antigen presenting pathway, 
also occurs via dendritic cells (Henderson R.A et al., 1997; Stenger S. et al, 1998). It has 
been noted that the high glycolipid content of the vesicles increases their antigen-
presenting ability because it enables them to stimulate DC using toll-like receptors (TLR) 
(Beatty W.L et al., 2000; Kaufmann S.H.E et al, 2006).  
 
1.3 Mtb Immune Evasion Techniques and Persistence in Macrophages 
1.3.1 Adaptation to the Intracellular Microenvironment 
The triumph of tuberculosis as a chronic infection hinges on its ability to establish a 
dormant state inside the host for many years, making it difficult to achieve sterile cure of 
disease even with multi-drug chemotherapy. The bacillus is able to survive and replicate 
for long periods in phagosomes by altering their normal state in a number of ways. 
Phagosomes are vacuoles inside phagocytes, which are macrophages with the endocytotic 
ability to engulf invading microorganisms, and are the direct product of the endocytic 
pathway. After being phagocytosed, M. tuberculosis firstly disturbs the normal 
maturation pathway of the phagosome. This prevents it from fusing with lysosomes to 
form a body called a phagolysosome, where invading microorganisms are degraded by 
hydrolytic enzymes (Hart P.D et al., 1972; Mwandumba H.C et al., 2004). This allows 
the bacteria to survive in immature phagosomes, where the iron-rich conditions favour 
growth and replication (Kaufmann S.H.E et al, 2006), and there is limited acidification 
because the vesicle compartment is deficient in the hydrolases present in lysosomes 
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(Russell D.G et al., 2002; Mwandumba H.C et al., 2004). Studies have shown that 
aborted fusion with lysosomes was commonly observed only with phagosomes that 
contained viable bacilli, demonstrating how an integral part of the ability of M. 
tuberculosis to survive inside phagocytes relies on its interference of phagosome-
lysosome fusion (Armstrong J. and D’arcy Hart P., 1971). Studies have also shown that 
M. tuberculosis is capable of adversely affecting the antigen-processing and -presenting 
capacity of macrophages by producing MHC I and II receptor inhibitors (Boom W.H et 
al., 2003). These are ways employed by the bacteria to evade destruction by the host’s 
immune system. 
 
1.3.2 Persistence in Macrophages 
After the immune system’s primary encounter with M. tuberculosis, the cell-mediated 
response results in the formation of granulomas, conglomerates of macrophages and 
lyphocytes, in the lungs. A granuloma effectively represents an attempt to contain the 
infectious agent whilst also providing a haven for their replication and survival, 
highlighting a paradox of tuberculosis infection. The cellular environment of granulomas 
is characterised by low pH, nutrient deficiency, hypoxia and the production of other 
inhibitory organic acids (Warner D.F and Mizrahi V., 2006). Furthermore, the bacillus is 
exposed to other immune effectors like ROI and RNI, which also act to drive it from the 
active replicating to the dormant state.  
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1.3.2.1 Low pH 
As previously described, phagosome maturation and subsequent phagosome-lysosome 
fusion is vital for bacterial killing, as the microbes are bombarded with bacteriocidal 
pore-forming peptides and lysosomal hydrolases (Flynn J.L and Chan J., 2001, 
Kaufmann S.H.E et al, 2006). Effective maturation of the phagosome is accompanied by 
a drop in the pH from neutral to acidic, which is the optimal environment required for the 
acidic hydrolases of the lysosomes to work after fusion has occurred (Hingley-Wilson 
S.M et al., 2003). M. tuberculosis expresses urease, which catalyses the production of 
ammonia (NH4+) and neutralises the pH of the phagosome, which is thought to arrest it in 
the early stages of development (Gordon A. et al., 1980).  It has also been shown that 
other tuberculosis-associated products and enzymes like sulfatides (Goren M. et al., 
1976) and glutamine synthetase (Harth, G. and Horwitz M.A, 1999) may also affect pH 
via ammonia production, but much speculation still surrounds exactly how this may be 
so.  
 
1.3.2.2 Hypoxia 
Low oxygen concentration and its effects on the control of bacterial replication has been 
one of the most comprehensively studied aspects of in vivo and in vitro research in 
tuberculosis. Oxygen depletion is another characteristic of the microenvironment of the 
granuloma and gives insight into how the bacillus is driven into a dormant state by 
hypoxia. In a landmark series of experiments, it was demonstrated how the gradual 
depletion of oxygen forces bacterial respiration not only to shift to involve nitrate 
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reduction (Wayne L.G et al., 1998) but also induces chromosomal, metabolic and 
structural changes in the dormant bacteria (Wayne L.G et al., 1979 and 1982). These 
studies went a long way to identifying the role of a prominent two component regulator 
system, DosR-DosS/DosT, of which the DosR regulon has turned out to be significantly 
important. This section of the MTB genome includes genes associated with multiple 
stresses known to drive the bacteria into a dormant state, including anaerobic respiration 
and non-toxic nitric oxide (NO) (Kendall S.L et al., 2004; Schnappinger D. et al., 2003).                 
 
1.3.2.3 Nutrient starvation 
Nutrient limitation is also thought to occur when M. tuberculosis resides inside the 
phagsome and granuloma, depriving the replicating bacteria of an adequate food source 
and essential elements that are vital for proper development. Recent in vitro starvation 
models that mimic intracellular conditions as closely as possible have allowed for the 
identification of metabolites and broad conditions that illustrate how persistence in 
macrophages can result. Glucose deficiency has been shown to be relevant, as well as 
over-production of fatty acids (McKinney J. D et al., 2000; Betts, J.C et al., 2002). In 
general, the up-regulation of genes involved in β-oxidation, gluconeogenesis, the 
glyoxylate shunt, RNA synthesis and amino acid/amine degradation was observed, whilst 
those associated with de novo ATP production, carbon degradation, and 
purine/pyrimidine synthesis were down-regulated (Betts, J.C et al., 2002; Hampshire T. et 
al., 2004). Depletion of isocitrate lyase, which is an important enzyme in fatty acid 
metabolism and bacterial replication in late-stage infection in mice, has given strong 
evidence that fatty acids are critical in times of nutrient starvation. When present in 
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normal amounts, bacteria were capable of replicating normally, which was still the case 
when the isocitrate lyase gene was disrupted in IFN-γ knockout mice (McKinney J. D et 
al., 2000). This meant that IFN-γ-producing macrophages deprive the bacteria of carbon-
based nutrients and forced its metabolism to switch to fatty acid breakdown, which 
demonstrated how the host’s immune activation can act to curtail the survival pattern of 
the bacterium. In murine models, the transcription profile of the MTB genome was also 
seen to change to produce more siderophores, which facilitated in the uptake of more iron 
which was necessary for growth (Timm J. et al., 2003).  
 
1.3.2.4 Free Radical-based Intermediates 
The most effective effector molecules encountered by M. tuberculosis in the cell are 
reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI). These 
compounds are produced by activated phagocytes that generate nitric oxide (NO) and 
related RNI via NOS2 using L-arginine as the substrate (Flynn J.L and Chan J., 2001). 
The role of RNI in controlling acute and chronic MTB infection has been well 
documented, showing that it not only has a protective role in mice (MacMicking J. et al., 
1997; Shiloh M. and Nathan C.F, 2000) but also that it may augment the host defence in 
humans. Immunohistochemical analysis has detected high expression levels of NOS2 in 
pulmonary macrophages of people with active tuberculosis, as well as high levels of 
exhaled NO (Nicholson S. et al., 1998; Wang C-H et al., 1996). In contrast, the role of 
ROI in infection is still the subject of debate. It has been shown that hydrogen peroxide 
(H2O2) present in macrophages has a mycobacteriocidal effect, but the combined effect of 
ROI is yet to be confirmed conclusively. On one hand, the mycobacterium appears to 
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possess mechanisms of evading toxic ROI effects, such as releasing lipoarabinomannan 
(LAM) and phenolicglycolipid I (PGL-I) which are strong oxygen radical scavengers 
(Chan J. et al., 1989). Yet there is evidence that mice deficient in the NADPH oxidase 
complex do show a moderately increased susceptibility to M. tuberculosis infection 
(Adams L. et al., 1997).  
 
1.4 Identification of MTB-specific Antigens  
1.4.1 Genomic Profiling and the RD1 Expression Proteins 
The genome of M. tuberculosis spans about 4000 genes in total, and one of the first 
studies to recognise the importance of identifying MTB-specific antigens that would be 
useful in vaccine research and effective drug design was carried out in 1996. In order to 
qualify exactly how M. tuberculosis differs from BCG, which would provide insight into 
developing a better vaccine, a technique called subtractive genome hybridisation was 
carried out to identify genetic differences between M. tuberculosis, M. bovis and BCG 
(Mahairas et al., 1996; Mustafa A.S, 2005). Three regions of difference (RD), designated 
RD1, RD2 and RD3, were discovered. With respect to MTB infection, RD2 and RD3 
demonstrated little or no research potential, because they either showed too little 
homology with M. tuberculosis or M. bovis to be of any diagnostic use against TB, or 
because their encoded proteins showed little or no protective effects against TB in murine 
or human models (Brewer T.F and Colditz G.A, 1995). In contrast, RD1 was highly 
conserved in all tested laboratory and clinical isolates of M. tuberculosis, but absent from 
all BCG substrains (Mahairas et al., 1996), and interest in this has region prompted new 
and innovative research into host-pathogen interactions.  
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1.4.1.1 Latency and the DosR Regulon 
Recent experiments using gene expression profiling have studied the bacillus under 
different stress conditions that mimic in vivo characteristics of the bacteria in its dormant 
state. During latent infection, individuals appear healthy and disease-free, but harbour 
dormant bacteria that are virtually inactive metabolically and reproductively (Kaufmann 
S.H.E, 2006). The genes under the control of what has been named the DosR, or 
dormancy regulon, typify the profile of latent infection, and upregulated latency genes 
have been linked to nutrient starvation (Wayne L.G and Hayes L.G, 1996; Cole S.T et al., 
1998; Wayne L.G and Sohaskey C.D, 2001; Voskuil M.I, 2004), hypoxia (Rosenkrands I. 
et al., 2002; Leyten et al., 2006) and varying NO levels (Voskuil M.I et al., 2003). It has 
been shown that not all DosR genes are up-regulated during latency, whilst some non-
DosR-regulated genes are (Boshoff H.I and Barry C.E, 2005), and this could provide 
important clues as to which genes are of interest during the dormant phase of the 
bacterium. Characterising a set of latency antigens that are important would provide 
interesting candidates for postexposure vaccines, as they may be potentially protective 
proteins against progression to active disease. 
 
1.4.1.2 Reactivation 
Infected individuals stand a 10% chance that the latent condition may roll over into active 
disease, a state called reactivation. The clinical factors responsible for reactivation are not 
well understood but are thought to be the result of a temporary suppression of the 
immune response (Collins F.M, 1989; Rook G.A.W and Bloom B.R, 1994). It has been 
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determined that there is a shift from the Th1-biased response during latency to a Th2 one 
during reactivation, a pattern that was observed in the cytokine production in both CD4 
and CD8 T cells (Howard A.D and Zwilling B.S, 1999). During latency, infectious 
microbes are contained in macrophages which reside in granulomas that do not largely 
affect the surrounding tissue. However during reactivation, granulomas increase in size, 
form cavities and large amounts of bacteria (>1010 organisms) can escape and replicate 
extracellularly in the debris surrounding the granuloma (Kaufmann S.H.E, 2006). Gene 
expression profiling has thus identified proteins associated with reactivation of disease as 
useful vaccine candidates. 
 
1.4.1.3 Resuscitation 
The bacteria’s ability to regress to a stable but metabolically inactive state when grown 
under suboptimal conditions is referred to as ‘non-culturable’ (NC) in vitro (Shleeva M. 
et al., 2004). It is hypothesized that induction of the NC state may be an adaptive 
response of the bacillus to their metabolism being compromised by a missing growth 
factor, possibly the simultaneous action of several factors (Shleeva M. et al., 2004). The 
change-over from dormancy to a reactivated state can occur when these growth factors 
(such as oxygen and nutrients) which were removed from the growth medium are 
replenished. There is tentative evidence that reactivated mycobacteria can resuscitate 
other neighbouring microbes by secreting resuscitation-promoting factors or Rpf (Cohen-
Gonsaud et al., 2005). The Rpf of Micrococcus luteus has been shown to restore active 
growth to M. luteus cultures in the stationary growth phase, and five Rpf homologues 
specific for M. tuberculosis have demonstrated similar effects in M. tuberculosis cultures 
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(Mukamolova G.V et al., 2002; Munoz-Elias E.J et al., 2005). Very little is still known 
about the in vivo effects of Rpf proteins. 
1.4.1.4 Classic Vaccine or TB Control Antigens 
The serodiagnostic potential of various new vaccine candidates have been evaluated by a 
large number of research groups in the search for an effective vaccine with 
protein/peptide epitopes that are more MTB-specific and confer better protection than 
BCG. From the assortment of antigens that have generated particular interest, a group 
now referred to as classic or typical TB vaccine antigens have been identified. It is 
generally accepted that these antigens strongly induce cytokine production in the sera and 
whole blood supernatant of both actively and latently infected individuals, living in high 
and low endemic regions and across ethnic groups (Lalvani A. et al., 2001; Porsa E. et al., 
2006; Hoff S.A et al., 2007). Proteins produced from the culture filtrate of M. 
tuberculosis, such as ESAT-6, Ag85A, Ag85B and CFP10 have been shown to induce a 
protective immune response against M. tuberculosis in animal and human models (Wang 
J. and Xing Z., 2002; Doherty T.M, 2005). These antigens are currently being used to 
develop or optimise TB diagnostic assays (Samanich K.M et al., 2000; Porsa E. et al., 
2006) or are entering clinical trials subunit vaccines (Langermans J.A.M et al., 2005; 
Radoŝević K et al., 2007). TB10.4 is another recently identified protein that appears to be 
important for M. tuberculosis virulence and growth. It is strongly recognised by TB-
exposed individuals, and produces a high frequency of antigen-specific CD4+ T cells that 
correlate to protection against MTB. 
 
 
http://scholar.sun.ac.za/
 16
1.5 Immune Correlates of Protection against Disease 
1.5.1 The Importance of IFN-γ 
It has been well documented that in tuberculosis, as in many infectious diseases, the role 
of IFN-γ is of critical importance as it plays a pivotal role in the protective CMI response. 
It is produced by both CD4 and CD8 T cells, as well as natural killer cells (NK). As 
previously stated, IFN-γ, in concert with other cytokines, activates macrophages and 
begins the cascade of events that lead to granuloma formation and killing of infected cells 
by cytotoxic T cells. Using IFN-γ -/- mice, it has been shown that with depleted levels of 
or in the absence of IFN-γ, T cells still migrate to the lungs to form granulomas. 
However, due to the insufficient levels of the cytokine and poor resultant macrophage 
activation, these granulomas rapidly became necrotic and failed to contain the infection 
(Flynn J.L et al., 1993; Algood H.M.S et al., 2003). Genetic studies on patients with 
faulty IFN-γ receptor (IFN-γ R) have provided the most clear and striking proof that 
flaws in the pathway of this Th1 cytokine is closely associated with increased 
susceptibility to mycobacteria (Fletcher H., 2007). Patients with either completely 
defective IFN-γ R1 or IFN-γ R2 suffered recurrent infections with BCG and other 
mycobacteria that are typically known to be non-infectious, whilst partial deficiency in 
the IL-12 receptor (IL-12 R) led to increased susceptibility to mycobacteria (Newport 
M.J et al., 1996; Altare F. et al., 1998; Lichtenauer-Kalis E.G et al, 2003). Murine studies 
using gene knock-out mice (GKO) mice have shown that not only is macrophage 
activation low when IFN-γ is defective, but NOS2 expression is also low, resulting in 
unimpeded bacillary growth in the lung cavities (Dalton D.K et al., 1993).  
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Although IFN-γ is essential in controlling mycobacterial infection, it is also generally 
accepted that it cannot be the only cytokine important in directing the immune response 
during the course of tuberculosis. Like in many diseases, infection with TB is 
multifactorial and complex, and other correlates of protection need to be identified. A 
recent study has shown a poor correlation between the frequencies of IFN-γ-secreting 
cells and the level of protection against MTB (Majlessi L. et al., 2006). IFN-γ itself may 
be unreliable as an immune correlate when its effects are taken alone, as levels of 
production may vary in affected subjects. IFN-γ is produced by both healthy PPD+ 
patients and those with active disease, and even though it has been shown that its levels 
are depressed in actively infected people (Flynn J.L and Chan J., 2001, Raja A., 2004), 
this may be insufficient to distinguish latent and active disease. One study demonstrated 
that M. tuberculosis may prevent macrophages from adequately responding to IFN-γ, 
suggesting that the activated cells’ response to the cytokine may provide better 
indications as to disease progression than measuring levels of the cytokine itself (Ting 
L.M et al., 1999). Also, it appears that the initial surge of IFN-γ production, which 
indicates an assaulted immune system, usually leads to suppression of the infection by 
downregulating the cytokine response. However in the case of M. tuberculosis, where the 
bacilli can evade the host’s counter-attack mechanisms and continue to replicate, the 
immune response can remain elevated throughout infection without sterile cure being 
attained. IFN-γ alone cannot provide protective immunity, and in some scenarios its 
elevated levels can be detrimental rather than protective. It would be therefore be 
innovative to profile other cytokines that are associated with bacterial burden in an effort 
to establish their effect on immunity as well. 
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1.5.2 Associated Cytokines 
1.5.2.1 TNF-α, IL-6 and IL-12 
M. tuberculosis induces TNF-α secretion by macrphages, dendritic APCs and T cells, and 
has been well-recognised to play an important role with IFN-γ as a pro-inflammatory 
cytokine in tuberculous infection. Its exact role appears to be complex, but it has been 
implicated in macrophage activation, where it was shown that TNF-α- or TNF receptor- 
deficient mice died much more rapidly than control mice, with markedly higher bacterial 
burdens (Flynn J.L et al., 1995; Bean A.G.D et al., 1999). The cytokine appears to affect 
cell migration to and localisation at affected tissue sites. Its synergistic effects with IFN-γ 
to induce NOS2 has also been well characterised, showing its downstream importance in 
granuloma formation (Chan J. et al., 1992; Flynn J.L and Chan J., 1995). It also affects 
the expression of adhesion chemokines and their receptors, which also plays a role in 
granuloma formation.  
 
IL-6 is another cytokine with multiple roles in the immune system. It has pro-
inflammatory and haematopoietic functions, and also aids in the differentiation of T cells 
(Raja A., 2004). Its role has also been extended to T cell suppression. Studies provided 
evidence that IL-6 is vital in the innate response to the MTB pathogen by showing how 
IL-6 -/- mice had earlier and higher bacterial load in the lungs, in addition to decreased 
IFN-γ production (VanHeyningen T.K et al., 1997; Saunders B.M et al., 2000). IL-6 has 
also been shown to be stimulated by other bacterial components like endotoxins, of which 
lipopolysaccharide (LPS) and lipoarabinomannan (LPS) are examples (Zhang et al., 
1994, Christodoulides M. et al., 2002).  
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IL-12 is also closely associated with the development of a pro-inflammatory, Th1 
response. Its production follows the cell’s first encounter with M. tuberculosis, after 
phagocytosis of the bacillus by macrophages and dendritic cells (Ladel C.H et al., 1997), 
and its induction is strongly tied to enhanced mycobacterial resistance. Mice deficient in 
IL-12p40, its homodimer, showed a remarkably increased infection susceptibility and 
bacterial burden, and decreased survival time, which related to a reduction in IFN-γ 
production (Cooper A.M et al., 1997).  
 
1.5.2.2 IL-2 
This cytokine plays a critical part in the clonal expansion of lymphocytes that are specific 
to bacterial antigens, which is important for an immune response against mycobacteria 
(Raja A., 2004). IL-2 secretion also constitutes an important protective facet of the Th1 
response as it is produced by CD4 cells, and several studies have demonstrated that IL-2 
levels, alone or associated with that of other cytokines, can influence the outcome of 
mycobacterial infections (Blanchard D.K et al., 1989).  
 
1.5.2.3 IL-10 
IL-10 is an anti-inflammatory cytokine and has an immune inhibitory function. It is 
produced by macrophages and T cells and has macrophage-deactivating properties, which 
includes the down-regulation of IL-12 production, which subsequently leads to the 
decrease in IFN-γ production (Raja A., 2004). The cultured macrophages of patients with 
active TB were T cell-suppressive and inhibition of IL-10 partially reversed this pattern 
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(Gong J-H et al., 1996). IL-10 directly inhibits CD4+ T cell and APC function during 
infection (Rojas M. et al., 1999). Transgenic mice constitutively expressing IL-10 lacked 
an adequate ability to clear a chronic BCG infection, although T cell responses and IFN-γ 
production were unaffected. These results suggested that IL-10 may counteract the 
macrophage-activating properties of IFN-γ (Murray P.J et al., 1997).  
 
1.5.2.4 IL-4 
IL-4 typifies the profile of a Th2-skewed response, but its effects during MTB infection 
have been variable and controversial. In human studies, it was observed that a lowered 
Th1 but not a heightened Th2 response characterised the PBMC of tuberculosis patients 
(Zhang M. et al., 1995; Lin Y. et al., 1996). In the granulomatous lymph nodes of patients 
with tuberculous lymphadenitis, elevated levels of IFN-γ were found but IL-4 mRNA 
was difficult to detect (Lin Y. et al., 1996). This shows that in humans, a strong Th2 
response is not associated with tuberculosis. Murine infection models using knockout 
mice showed that in the absence of a reliable Th1 response, a Th2-directed outlook is not 
necessarily promoted, and it is an IFN-γ deficiency rather than the presence of IL-4 and 
other Th2 cytokines that prevents control of infection (Flynn J.L et al., 1993; Cooper 
A.M et al., 1997). How the presence of IL-4 affects clinical outcome still needs to be 
further elucidated. 
 
1.5.2.5 TGF-β 
This anti-inflammatory cytokine has its functions in inhibition of T cell proliferation 
(Rojas R.E et al., 1999), interference with NK and CTL function and downregulation of 
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IFN-γ, deactivation of the production of RNI and ROI by macrophages (Ding A. et al., 
1990), and TNF-α and IL-1 release (Ruscetti F. et al., 1993). It has been demonstrated 
that when TGF-β is added to co-cultures of mononuclear phagocytes and M. tuberculosis, 
both growth inhibition and phagocytosis were reduced in a dose-dependent manner 
(Toosi et al., 1995). The ability of macrophages to inhibit mycobacterial growth may 
depend on the relative influence of TGF-β and IFN-γ in infection (Raja A., 2004). 
 
1.5.3 Diagnosing Latent Tuberculosis Infection: Old and New Techniques 
Currently, diagnosing LTBI is still heavily reliant on the tuberculin skin test (TST), 
which is an intradermal inoculation of a mixture of over 200 M. tuberculosis proteins 
called a purified protein derivative (PPD). The underlying problem with this test is that is 
has poor TB-specificity in BCG-vaccinated people and low sensitivity in those with a 
suppressed cellular immunity, for example HIV-infected persons (Andersen P. et al., 
2000; Lalvani A., 2007). Two more specific methods that now exist for measuring TB 
antigen-specific T cell responses are the now-conventional ELISA method and the more 
recent multiplex technology. 
 
The whole-blood ELISA relies on measuring the release of IFN-γ within the T 
lymphocyte compartment, meaning production of the cytokine by antigen-specific T cells 
follows stimulation with mycobacterial antigens. The ELISA can be a commercially 
available assay that measures cytokine release after a 16 – 24hour incubation period 
(Desem N. and Jones S.L, 1998) or an in-house method designed to detect response 
levels after longer (2 – 7 day) periods. One fundamental drawback of whole blood ELISA 
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is that it can usually measure only one to a few cytokines. This is in stark contrast to the 
multiplex technique that has the potential to measure up to 100 different cytokines in a 
50μl sample. This fluorescent bead-based technology is becoming a very popular method 
of detecting a mixture of cytokines in serum, supernatant and PBMC of humans and mice 
(Oliver K.G et al., 1998; Carson R.T and Vignali D.A, 1999; Kellar K.L et al., 2001). 
Both these assays are very important in improving and expanding current knowledge on 
the cytokines produced and detectable during LTBI in humans. 
 
1.6 Summary 
The exact correlates of protection against MTB during latent tuberculosis infection are 
not yet known or fully understood. The protective efficacy of BCG has proven to be 
highly variable in different populations and geographic regions, not to mention its 
protective effects in children wanes significantly with age and is affected by coincident 
exposure to environmental mycobacetria (De Groot A.S et al., 2005; Gupta U.D et al., 
2007). In order to find a new vaccine that effectively controls TB infection, these issues 
must be tackled. Finding a new vaccine against TB would entail further elucidation of the 
infectious profile, indentifying new antigen components that could provide better 
protection and investigating novel vaccine delivery systems. There is urgent need for a 
well-defined profile of immunity with respect to the cytokines and chemokines produced 
during LTBI, as well as for the development and optimisation of reliable assays that can 
competently measure the response itself. This project, to my knowledge, describes the 
first large-scale attempt to: (i) quantify the IFN-γ responses to a panel of TB-specific 
antigens using WBA and ELISA, (ii) identify other immune correlates of protection after 
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antigen stimulation using the Luminex technology and (iii) compare the two techniques 
as viable tools for researching TB, in a South African population.  
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                                             CHAPTER 2 
                                    
Screening of Novel MTB Antigens by IFN-γ ELISA in a 
population with a high incidence of LTBI 
 
2.1 Antigen Screening 
2.1.1 Background 
An estimated one-third of the world’s population is latently infected with tuberculosis, 
and the most effective intervention to counter spread of the disease would be the 
development of a competent postexposure vaccine. In 2003, the Grand Challenges in 
Global Health initiative was launched by the Bill and Melinda Gates Foundation to 
address pertinent research questions surrounding infectious diseases worldwide, and 
Grand Challenge 6-74 (GC6-74) was specifically targeted at TB research. The goal of 
this major study was to characterise the immune response to TB infection by identifying 
immune correlates of protection and host markers of active disease with prognostic 
potential. GC6-74 is a collaborative research effort, and one of the African field sites and 
research groups was established at Stellenbosch University in Cape Town. 
 
This project was a study within the larger GC6-74 plan, and was designed to outline the 
natural protective immune profile of latently infected individuals by observing their IFN-
γ responses to novel MTB antigens. A chosen panel of 78 antigens were used in the 
screening exercise, composed of 67 antigens from Leiden University Medical Centre 
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(LUMC, Netherlands) and the Max Planck Institute for Infection Biology (MPIIB, 
Germany), and 11 antigens from Statens Serum Institute (SSI, Denmark). These MTB 
proteins were produced using in vitro gene expression models that mimic the reaction of 
the bacillus under different stress conditions, a collaborative effort of the Schoolnik Lab 
(Stanford University) and SSI. The expression products were accordingly named latency, 
reactivation, resuscitation promoting factor (Rpf) or classic control antigens.  
 
2.1.2 Setting 
The epidemiological field site is situated in Cape Town, South Africa, which has one of 
the highest incidence rates of tuberculosis worldwide. In the surrounding suburbs, the 
annual risk of TB infection is 3.5% - 10 times the already high risk for sub-Saharan 
Africa (Walzl G. et al., 2005). Study participants were members of the Uitsig, 
Ravensmead, Adriaanse or Elsiesriver communities, which have long been recognised as 
specific areas with a high burden of TB infection, an incidence rate that is not overly-
exacerbated by a high HIV prevalence. A typical ethnic profile shows these communities 
are largely inhabited by the Coloured (Brown) racial group. Participants were recruited 
from Tygerberg Hospital as well as smaller community clinics in the respective 
neighbourhoods.  
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2.1.3 Experimental Design 
This study followed a cross-sectional study design, where prospective patients were 
recruited for the study over a total time-course of 18 months, following evaluation of 
their suitability for inclusion. The following study cohorts were identified according to 
their corresponding criteria:  
1) TB Index cases - New TB cases were identified by research nurses through clinic 
registers and introduced to the study upon diagnosis with active TB. TB was 
diagnosed on the basis of at least 2 Zheil-Neelsen (ZN) positive sputum smears, 
and chest x-ray. After diagnosis, written informed consent was obtained for 
recruitment and patients were enrolled. The TB cases themselves were not 
investigated in the present study but were used to identify household contacts. 
2) Household contacts (HHCs) of Index cases – After identification and recruitment 
of the Index cases, permission was obtained to visit their homes and recruit 
household members with whom they had close daily contact. Written informed 
consent was obtained for recruitment and household contacts were enrolled.  
 
2.1.4 Participant Selection Criteria 
Consent and Ethical Approval 
Ethics approval from the Ethics Committee of Stellenbosch University was obtained prior 
to beginning the study, to allow patient participation. Trained research nurses thoroughly 
explained the study in basic terms to prospective participants. Informed, written consent 
was obtained from all persons aged 15 and older, or from the guardian of recruits who 
were younger than 15 years old. All study participants were tesed for HIV infection. Pre- 
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and post-test counselling was given to every subject, and his/her guardian where age 
appropriate.  
 
Inclusion Criteria:  
All participants had to be HIV-1 negative, confirmed by a HIV rapid test taken upon 
recruitment or proven test results not older than 3 months. For the skin test, 0.1ml or 5 
tuberculin units (TU) of tuberculin purified protein derivative (PPD) was injected 
intradermally. All participants had to be available for measuring the TST induration after 
48-72 hours and to have a posterior-anterior chest X-ray radiograph taken. Any 
household contacts that displayed symptoms of TB or lung disease were also excluded.   
In addition, they also had to fulfil the following criteria:  
 Be a community member living in the study area for over  3 months and have a 
permanent address  
 Be aged 10 to 60 years,  
 Be willing to have a chest X-ray, or have a previous, recent chest X-ray examined 
to clear the patient of active TB disease.  
Exclusion Criteria:  
Defaulting on any one or more of the following criteria was grounds for exclusion:  
 Living in the study area for < 3 months and/or no permanent address, 
 Previous or current treatment for TB or HIV-1,  
 Current or recent (within 6 months) participation in a vaccine/drug trial,  
 Concomitant cancer or diabetes mellitus,  
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 Chronic emphysema/ bronchitis/ asthma requiring systemic steroid therapy, or 
any steroid therapy within the past 6 months, and  
 Pregnancy (current or within the past 3 months).  
 
Subsequent to evaluating if a recruit was eligible for inclusion and obtaining written 
consent, venous blood was taken before administration of the PPD injection and 
transported to the laboratory strictly within 2 hours of collection. A sputum sample was 
also collected for smear and culture M. tuberculosis testing. 
 
Final Participant Cohort 
The final participant cohort selected for this study consisted of 2 groups of healthy, HIV 
negative household contacts of newly diagnosed pulmonary TB cases. A subset of 67 
antigens from LUMC and MPIIB were tested on the first group of 38 and another set of 
11 antigens from SSI were tested on the second group of 19.  
 
Recruitment for the antigen screening study was a continuous process throughout the 
course of the project, but availability of the antigens was a major determinant with 
respect to when experiments could be designed and conducted. For this reason, the first 
group of 38 individuals were screened earlier with the available 67 antigens, and a second 
experiment for the SSI antigens was undertaken at a much later time with a smaller 
group. 
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For both the SSI antigen screening and the Luminex studies, 20 participants (group 2) 
were recruited. One participant was excluded very early on because of sample 
contamination. It was later discovered that 5 participants (including the first exclusion) 
were TST-negative and their results were not deemed useful for study purposes at that 
time. For the sake of completeness, the SSI ELISA data showed results for 19 people 
(only one exclusion) but all data for the Luminex and comparing ELISA and Luminex 
showed results for only 15 people (all 5 TST-negatives excluded).  
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2.2 Materials and Methods 
2.2.1 Antigen Classification of Proteins provided by the LUMC and MPIIB 
The antigens for screening were either recombinant proteins or peptide pools. All 
recombinant antigens were screened at a final concentration (after addition of blood) of 
10μg/ml and peptide pools were tested at either 10μg/ml or 1μg/ml final concentration 
per peptide. Tables 1, 2, 3 and 4 show the range of antigens that were tested in the first 
round of the antigen screening experiment. 
 
Table 1: List of the 6 Classical TB Vaccine* antigens tested.  
ANTIGEN NAME 
MTB 
GENE 
REGION 
PROTEIN 
SIZE 
(a.a.) DESCRIPTION 
TB10.4 (Rv0288) esxH 96 
Low molecular weight protein Antigen 7; Classical 
Antigen 
**Ag85A (Rv3804c) fbpA 338 Secreted Antigen 85A; Classical Antigen 
**Ag85B (Rv1886c) fbpB 325 Secreted Antigen 85B; Classical Antigen 
HSP 65 (Rv0440) groEL2 540 Heat Shock Protein 65; Classical Antigen 
TesatCFP10 
fusion 
product - ESAT-6 and CFP-10 fusion protein; Classical Antigen 
Rv3019 esxR 96 TB10.3; Secreted ESAT-6-like protein  
ESAT-6 esxA 95 RD1 Protein; Classical Antigen 
 
Tascon et al.; 1996 Nat. Med. 2 (8):888-92  
Huygen et al.; 1996 Nat. Med. 2(8):893-8 
Brandt et al.; 2000 Infect. Immun. 68(2):791-5 
Olsen et al.; 2004 Infect. Immun. 72(10):6148-50 
McShane et al.; 2004 Nat. Med. 10(11):1240-4 
Brandt et al.; 2004 Infect. Immun. 72(11):6622-32 
Skeiky et al.; 2004 J. Immunol. 172 (12):7618-28 
Langermans et al.; 2005 Vaccine 23(21):2740-50 
Williams et al.; 2005 Tuberc. 85(1-2):29-38 
Irwin et al.; 2005 Infect. Immun. 73(9):5809-16 
NB: All references cited refer to studies evaluating one or more of the classical TB antigens. 
NB*: These proteins are all encoded by the RD1 or the DosR regulon of M. tuberculosis. Rv-numbers denote the 
names of the protein products. RD1 indicates the region of difference 1 and a.a indicates amino acid.  
NB**: The two antigens of the Ag85 complex were screened as one, as the pooled peptide product Ag85A/B. 
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Table 2: List of the 35 DosR regulon Latency Antigens tested.  
ANTIGEN NAME 
MTB GENE REGION OR 
PROTEIN FUNCTION PROTEIN SIZE (a.a.) 
Rv2628 HP 120 
Rv2626c CHP 143 
Rv2031c acr (HSPX) 144 
Rv1733c  Possible transmembrane protein 210 
Rv2029c pfkB 339 
Rv2627c CHP 413 
Rv0569 CHP 88 
RV2623 TB31.7 297 
Rv0079 HP 273 
Rv0080 HP 152 
Rv0081 Transcriptional regulator 114 
Rv0571c CHP 443 
Rv1738 CHP 94 
Rv3134c CHP-USPA motif 268 
Rv3132c devS 578 
Rv3133c dosR 217 
Rv0570(Cpart) nrdZ 
combined 692 Rv0570(Npart) nrdZ 
Rv0572c HP 113 
Rv0573c CHP 463 
Rv0574c CHP 380 
Rv1734c HP 80 
Rv1735c CHP 165 
Rv1736c(Cpart) narX 
combined 652 Rv1736c(Npart) narX 
Rv1737c narK2 395 
Rv1812c HP 400 
Rv1813c HP 143 
Rv1996 CHP-USPA motif 317 
Rv1997-C ctpF 
combined 905 Rv1997-N ctpF 
Rv1998 CHP 258 
Rv2003c CHP 285 
Rv2004c CHP 498 
Rv2005c CHP-USPA motif 295 
Voskuil et al. 2003,J.Exp.Med. 198(5): 705-13 (Schoolnik Lab) 
Rosenkrands et al. 2002, Bacteriol. 184(13):3485-91 (Andersen Lab) 
Leyten et al. 2005, Micr.Infect. 8(2006): 2052-2060 
NB: Rv-numbers denote the names of the protein products. Italicised names designate the gene region and capitals the 
protein function. HSP indicates heat shock protein, and CHP and HP indicate conserved hypothetical and hypothetical 
proteins. 
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Table 3: List of the 5 Resuscitation-promoting factors (Rpf) tested.  
ANTIGEN 
NAME 
MTB 
GENE 
REGION 
PROTEIN 
SIZE 
(a.a.) DESCRIPTION 
Rv0867c rpfA 407 Possible Resuscitation-promoting factor RPFA 
Rv1009 rpfB 362 Possible Resuscitation-promoting factor RPFB 
Rv1884c rpfC 176 Probable Resuscitation-promoting factor RPFC 
Rv2389c rpfD 154 Probable Resuscitation-promoting factor RPFD 
Rv2450 rpfE 172 Probable Resuscitation-promoting factor RPFE 
 
Mukamulova et al.; 1998 PNAS 95:8916-21 
 
NB: Rv-numbers denote the names of the protein products. Italicised names designate the gene region and capitals the 
protein function, and a.a indicates amino acid. 
 
Table 4: List of the 21 Reactivation Antigens, produced by the Wayne model, tested.  
ANTIGEN 
NAME 
MTB GENE REGION or PROTEIN 
FUNCTION PROTEIN SIZE (a.a.) 
Rv0140 CHP 126 
Rv0246  Probable conserved integral membrane protein 436 
Rv0251c hsp 159 
Rv0331 Putative dehydrogenase 388 
Rv0384c clpB 848 
Rv0753c mmsA 510 
Rv1073 CHP 283 
Rv1115  Possible Exported Protein 232 
Rv1130 CHP 526 
Rv1131 gltA1 393 
Rv1471 trxB 123 
Rv1717 CHP 116 
Rv1874 HP 228 
Rv1875 CHP 147 
Rv2090 Probable 5’-3’ Exonuclease 393 
Rv2465c rpi 162 
Rv2466c CHP 207 
Rv3054c CHP 184 
Rv3223c sigH 216 
Rv3307 deoD 268 
Rv3407 * CHP 99 
 
NB: Rv-numbers denote the names of the protein products. Italicised names designate the gene region and capitals the 
protein function, and a.a indicates amino acid. HSP indicates heat shock protein, and CHP and HP indicate conserved 
hypothetical and hypothetical proteins.  
NB*: This was the only antigen kindly provided by the MPIIB. 
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2.2.2 Tissue Culture Assay Set-up 
All standard tissue culture methods were strictly observed under thoroughly sterile 
conditions. 
 
Antigen Reconstitution  
Antigens were received in different amounts, either in lyophilised powder form (LUMC) 
or in solution (SSI). Lyophilised antigens were reconstituted to a stock concentration of 
0.5mg/ml prior to being made up to a working dilution of 20μg/ml. To reconstitute, half 
of the total volume of sterile 1X PBS (Cambrex, Whitehead Scientific) required to 
solubilise the antigens to a concentration of 0.5mg/ml was initially added to the 
lyophilised proteins (dilution volume varied according to original concentration). The 
contents of the tubes were mixed well and placed in a 37oC waterbath for 20 minutes. If 
the protein contents were not fully dissolved, the tubes were held in a sonicating 
waterbath for a few seconds intermittently until the powder went into solution. The 
solution was then transferred to a Greiner 15ml tube (LASEC) and the remaining 1X PBS 
was added. Finally, a volume of serum-free RPMI-1640 (Sigma) with L-glutamine 
(Sigma) at a 1% concentration was added to bring the solution to a working concentration 
of 20μg/ml. Antigens received already in solution (SSI) were directly made up to the 
same working dilution with RPMI + 1% L-glutamine. 
 
Culture Plate Preparation 
After reconstitution, the proteins or peptides at 20μg/ml were used to make frozen 
antigen plates for storage prior to whole blood assay. In a sterile laminar flow hood, 
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100μl/well of each antigen, in triplicate, was aliquoted onto labelled 96-well, U-bottom 
tissue culture plates (AEC Amersham). Staphylococcus enterotoxin B (SEB, Sigma) at 
0.1μg/ml and/or phytohaemagglutinin (PHA; Sigma) at 5μg/ml were used as the positive 
stimulated culture controls on each plate, and plain RPMI with 1% L-glutamine as the 
unstimulated control. Empty wells were filled with distilled autoclaved water to prevent 
excessive evaporation from the plate during incubation.  
 
2.2.3 Blood Processing 
Blood Collection 
Venous whole blood was aseptically collected from each participant into 10ml glass 
sodium heparin vacutainers (Becton Dickinson, Scientific Group). Blood tubes were 
transported to the laboratory at room temperature and processed strictly within 2 hours of 
collection in a laminar flow hood.  
 
Whole Blood Assay (WBA) 
Whole blood (2ml) was diluted 1 in 5 with RPMI-1640 with L-glutamine added to a 1% 
concentration. An aliquot of 100μl of blood/well was pipetted onto thawed antigen plates 
to make a final antigen concentration of 10μg/ml per well. Antigens were tested in 
triplicate. Culture plates were incubated for 7 days at 37oC and 5% CO2 in a humidified 
incubator. After the incubation period, the supernatant (SN) was carefully harvested off 
each well to avoid disturbing the layer of sedimented red blood cells. Replicate 
supernatants were pooled and mixed to ensure sample uniformity, and then separated into 
3 aliquots: 210μl and 110μl aliquots of the pooled supernatant were stored on separate 
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96-well plates and another 110μl in 1.5ml Cap E™ eppendorf tubes (Merck). The 96-well 
storage plates were sealed with microtitre plate sealing tape (AEC Amersham) plus a lid. 
All tubes or plates were allocated a position on a computerised sample storage database 
before being frozen at – 80oC until use. 
 
2.2.4 IFN-γ Enzyme-linked Immunosorbent Assay (ELISA) 
Materials and Reagents 
Coating buffer: 0.1M NaHCO3 in distilled water (dH2O), pH 8.2 
Blocking Buffer: 1X PBS with 10% heat inactivated foetal calf serum (HI FCS). FCS 
was heat inactivated for 30 minutes at 56oC.  
Wash buffer: 1X PBS with 0.05% Tween20 (Sigma) 
Diluent solution: RPMI-1640 with 5% HI AB serum 
Avidin peroxidise solution: 1/400 dilution of avidin peroxidise (Sigma) in blocking 
buffer 
Capture antibody solution: 1/500 dilution of purified mouse α-human IFN-γ monoclonal 
antibody, clone NIB42 (BD Pharmingen) in coating buffer 
Detection antibody solution: 1/500 dilution of biotinylated mouse α-human IFN-γ 
monoclonal antibody, clone 4S.B3 (BD Pharmingen) in blocking buffer 
IFN-γ Standard solution: 1/250 dilution of 1μg/ml IFN-γ standard (Pharmingen) in 
diluent solution. 
OPD FAST solution: 1 gold (urea peroxidise) and 1 silver (OPD) tablet (both Sigma), 
dissolved in 20ml dH2O/ELISA plate. 
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ELISA 
This protocol describes an indirect sandwich ELISA. Wells of the 96-well ELISA plates 
(AEC Amersham) were coated with 50μl/well of capture antibody solution and left to 
incubate overnight at 4o C. The following day, plates were washed with wash buffer and 
blocked with 150μl of blocking buffer for 2 hours at room temperature (RT). After the 
blocking step, plates were washed again with wash buffer and 100μl/well of harvest 
supernatants were added in duplicate. IFN-γ standard solution and a positive internal 
control standard (pooled supernatant from a mitogen-stimulated WBA) were also added 
for the standard curve and internal positive control respectively. Plain diluent was added 
as the blank. Plates were incubated overnight at 4o C. For detection, 100μl/well of 
detection antibody solution was added after plates were washed. After 1-hour incubation 
at RT, 100μl/well of avidin peroxidase solution was added, followed by another 
incubation period of 1 hour at RT, after which plates were washed. For the final detection 
step, 200μl/well of OPD FAST substrate was pipetted onto plates. Plates were incubated 
in the dark for 25 minutes at RT for colour development, and then optical density (OD) 
was read at 450nm on an ELISA plate reader.  
 
The standard curve was generated using a serial dilution of the IFN-γ standard. There 
were two different ranges for the standard curves used for the ELISA, though the method 
for the assays was similar. Both were 8-point curves, but the top and bottom values were 
4000 and 31.25pg/ml for one curve and 2000 and 15pg/ml for the other. This provided 
the distinction for the cut-off used to define positivity of the response, which was 
30pg/ml for the LUMC antigens and 62.5pg/ml for the SSI antigens. 
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2.3 Results 
 2.3.1 Demographics of the Final Participant Groups 
The two final participant groups, group 1 and group 2, both consisted of healthy, HIV 
negative adults that were HHCs of Tb Index cases, recruited from the nearby community 
study areas (Tables 5 and 6). Group 1 were tested on a panel of 67 antigens provided by 
Leiden University Medical Centre (LUMC) and Max Planck Institute for Infection 
Biology (MPIIB) and Group 2 were tested on a panel of 11 antigens provided by Statens 
Serum Institute in Denmark. Approximately three times more women than men were 
present in group 1 and four times more in group 2.  All participants were of the Coloured 
(Brown) race except for one person in group 1.  
 
Table 5: Participant demographic data for Group 1 (n = 38). All participants were TST 
positive. 
GENDER SPREAD AGE RANGE TST READING (mm) RACE 
Male Female 
18 - 56 years ≥ 10mm - 37mm 
37 Coloured 
11 27 1 Black 
 
Table 6: Participant demographic data for Group 2 (n = 19). 4 participants were 
tuberculin skin test (TST) negative (0mm) and 15 were TST-positive (>10mm).  
GENDER SPREAD AGE RANGE TST READING (mm) RACE 
Male Female 
12 - 51 years 0mm - 34mm All Coloured 8 11 
 
 
 
http://scholar.sun.ac.za/
 38
2.3.2 Gradient of Exposure 
The gradient of exposure describes the level of contact between the recruited household 
contact and the diagnosed TB index case, taking note of the closeness of contact within a 
shared living area as well as the number of hours of exposure. Tables 7 and 8 show the 
gradient of exposure for group 1 and group 2 respectively. Exposure place describes the 
living area where the majority of exposure to an actively TB-infected person took place, 
with the yard being the lowest level of exposure and a shared room the highest. Exposure 
time was the total number of hours per day spent in the company of the infected person. 
 
Table 7: Gradient of Exposure for Group 1.  
 EXPOSURE PLACE EXPOSURE TIME (hours)   
 Yard House Room ≤ 3 4-7hrs 8-11hrs ≥ 12hrs 
Number of People 8 21 9 12 3 5 18 
 
 
Table 8: Gradient of Exposure for Group 2.  
 EXPOSURE PLACE EXPOSURE TIME (hours)   
 Yard House Room ≤ 3 4-7hrs 8-11hrs ≥ 12hrs 
Number of People 9 9 1 3 2 3 11 
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2.3.3 Validation of the IFN-γ ELISA using the Internal Positive Control 
The internal positive control used as an ELISA positive standard was a pooled mitogen-
stimulated supernatant from a 7-day WBA. The ELISAs were usually done in batches of 
5-7 plates/batch. The performance of the positive control standard on each plate was used 
as an indicator of inter-well variation within a plate, and inter-plate variation. Figure 2 
shows a representative spread of internal control values observed for 4 ELISA batches 
done over the course of the antigen screening study. In our lab, internal positive control 
values in the range of 950-1600pg/ml were generally accepted as normal. 
 
 
0
500
1000
1500
2000
2500
0 1 2 3 4 5 6 7 8
Plate Number
C
on
ce
nt
ra
tio
n 
(p
g/
m
l)
ELISA Batch 1
ELISA Batch 2
ELISA Batch 3
ELISA Batch 4
 
Figure 2: Comparison of the Internal Positive Control standard within ELISA batches. A 
typical ELISA batch consisted of 5 – 7 plates run on the same day. The internal positive 
control was added to each plate in duplicate, and the mean value (in pg/ml) of the wells 
was taken as the readout.  
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2.3.4 Statistical Analysis 
To characterise the groups of responders according to levels of responses, response 
categories were defined and displayed in the figure key as follows: nil (0 – 30pg/ml), low 
(31 – 125pg/ml, indictaed by blue colour), intermediate (126 – 1000pg/ml, indictaed by 
purple colour) and high (> 1000pg/ml, indictated by cream colour). These categories 
were assigned in accordance with points on the standard curve. Grouping of the mean 
values and generation of graphs was done using basic Microsoft® Excel software.  
 
2.3.5 Group 1 IFN-γ Responses to LUMC and MPIIB Antigens 
2.3.5.1 Responses to Classic TB Antigens 
IFN- responses to the classical TB antigens are shown in Figure 3. Generally, the 
highest percentage responders were observed to recombinant ESAT-6 and the fusion 
protein TesatCFP-10, with positive responses in 85% and 80% of individuals 
respectively. 61% of responses to ESAT-6 fell within the medium-to-high range (126 – 
1000pg/ml) with 17% of responders producing over 1000pg/ml IFN- to this antigen. The 
frequency of response to TesatCFP-10 was more evenly divided, with 38% of positive 
responses in the moderate range and 26% in the high range. Individuals tended not to 
respond as well to Rv3019 (TB10.3), a secreted ESAT-6-like product, as they did to 
either ESAT-6 itself or the fusion protein, only half the number of participants (40%) 
being responsive to this antigen. Just over 31% showed a positive response to TB10.4, 
with approximately 50% showing moderately high IFN-γ production. Less than 10% of 
individuals responded to Ag85A/B and only 3% to HSP65. There was a high frequency 
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of positive responses (77%) to the mitogen phytohaemaglutinin (PHA), equally divided 
between moderate and high pg/ml values.  
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Figure 3: Percentage of positive responses to Classic TB antigens. ESAT-6, Rv3019c (a 
secreted ESAT-6-like protein), TesatCFP10, TB10.4 and Heat shock protein 65 (HSP65) 
were all recombinant antigens tested at a final concentration of 10μg/ml. The 
recombinant proteins of Antigen 85A and B were pooled (Ag85A/B) and both tested at 
10μg/ml final concentration. Phytohaemaglutinin (PHA) was used as the positive control 
and tested at 5μg/ml. IFN-ELISA was performed on 7-day whole blood culture 
supernatants of TST positive, HIV negative patients (n = 38).  
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2.3.5.2 Responses to Latency Antigens 
Figure 4 shows the frequency of responses to the latency antigens that elicited a positive 
IFN-response in the group tested. The two antigens eliciting the highest responses were 
Rv1733c and Rv1737c, with 45% and 43% of positive responders respectively. Four 
antigens, Rv1735c, Rv1736c, Rv0081 and Rv1996 produced a response in 28 – 38% of 
individuals. An additional four antigens elicited positive IFN-γ responses in 19% of those 
tested. Eight antigens (Rv1737c, Rv1735c, Rv1736-C, Rv1996, Rv1813c, Rv1997-C, 
Rv2031c and Rv0573c) elicited a moderate to high response (126 - 1000pg/ml) in over 
50% of the people they were tested on, and an additional 4 antigens (Rv1733c, Rv0081, 
Rv1812c and Rv1997-N) did likewise in about 25% of responders. None of the latency 
antigens on the panel stimulated a positive response higher than 1000pg/ml. 
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Figure 4: Percentage of responders to Latency antigens. IFN- ELISA was performed on 
7-day whole blood culture supernatants of TST-positive, HIV-negative participants (n = 
38).  
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2.3.5.3 Responses to Resuscitation Promoting Factor (Rpf) Antigens 
The frequency of responses to all the RPF antigens is summarized in Figure 5. The 
overall response to the RPFs was second only to the response to most of the classical TB 
antigens, both in terms of the magnitude of response and the percent responders. At least 
30% of participants produced a positive response to each individual RPF antigen. 
Positive IFN-γ responses were more or less equally divided between low and moderate-
to-high levels in response to Rv0867, Rv2389, Rv2450c and Rv1009. In addition, 5% of 
responders (n = 3) produced IFN-γ levels in the high range (over 1000pg/ml) for these 
same four RPFs. The lowest levels of IFN-γ production (30 – 125pg/ml) were produced 
in response to Rv1884c, which also induced the lowest percent of responders.  
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Figure 5: Percentage of responders to Resuscitation-promoting factor (RPF) antigens. 
IFN-γ  ELISA was performed on 7-day whole blood culture supernatants of TST-
positive, HIV-negative participants (n = 38).  
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2.3.5.4 Responses to Reactivation Antigens 
Figure 6 shows the frequency of responses to the 13 out of 21 reactivation antigens tested 
that generated a response above 30pg/ml. In general, the profile of responses to the 
reactivation antigens was poor in comparison to the other types of antigens. The 
percentage of responders was only 5% for most of the antigens, and for 8 of the 21 
proteins tested there was no response observed in any of the participants (results not 
shown here). IFN-γ responses above 125pg/ml were only produced by 5 reactivation 
proteins, the highest IFN- levels being induced by Rv1131 (24% of people produced 
both low and moderate/high level responses respectively) and Rv1115 (14% of people 
producing both low and moderate/high level responses respectively). In comparison, only 
15% of participants responded to Rv3862, Rv0246 and Rv0331. 
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Figure 6: Percentage of responders to Reactivation antigens. IFN-γ  ELISA was 
performed on 7-day whole blood culture supernatants of TST-positive, HIV-negative 
participants (n = 38).  
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2.3.6 Group 2 IFN-γ Responses to SSI Antigens 
2.3.6.1 Antigens Used 
A small panel of antigens was provided by SSI for testing. As much smaller quantities of 
protein were supplied, the antigens were only tested on a group of 19 people (group 2). 
The antigens tested were TB10.4 (peptide pool), ESAT-6 (peptide pool), Ag85B 
(recombinant), and peptide pools of Rv2654, Rv2659A, Rv2659B, Rv2659C, Rv2660, 
Rv2661, Rv2662 and Rv2663. The peptide pools arrived pre-pooled from SSI and were 
tested at a final concentration of 10 and 1μg/ml per peptide, whilst the recombinant 
protein were tested at 10μg/ml final concentration. In addition, SEB at 0.1μg/ml and PHA 
at 5μg/ml were used as the positive control stimulants. IFN-γ ELISA were performed on 
7-day WBA supernatants of participants. 
 
2.3.6.2 Responses to SSI Antigens 
Figure 7 below shows the frequency of responses to the SSI panel of antigens. All 
participants showed a very strong response to the positive control stimulants SEB and 
PHA. The classical TB control antigens TB10.4 and ESAT-6 showed the highest 
frequency of responses in participants, which was comparable to responses observed in 
the Group 1 cohort. The peptide pools of these proteins induced responses more 
frequently at 10μg/ml than at 1μg/ml. Stimulation with TB10.4 and ESAT-6 at the higher 
concentration produced a positive response in 37% and 47% of responders respectively  
(n = 7 and n = 9), in comparison to 26% and 32% (n = 5 and n = 6) respectively at the 
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1μg/ml concentration. Recombinant Ag85B, which was tested at 10μg/ml, induced 
responses in only 2 participants (10.5% of responders). 
In general, there was a low frequency of responses observed to the other peptide pool 
antigens (data not shown here). Only Rv2654 and Rv2659C stimulated notable positive 
reactions in participants (37% and 32% of responders respectively). Each of the other 6 
non-control antigens, Rv2569A, Rv2659B, Rv2660, Rv2661, Rv2662 and Rv2663, 
elicited low responses in only one or two participants. 
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Figure 7: Frequency of positive responses to SSI antigens. ELISA was performed on 7-
day whole blood culture supernatants of HIV-negative participants of cohort Group 2 (n 
= 19). The blue bars indicate peptide pool antigens tested at 1μg/ml and the red bars, with 
the exception of Ag85B, indicate peptide pools tested at 10μg/ml. Recombinant Ag85B 
was also tested at 10μg/ml final concentration. Positivity of the assay was defined as 
greater than twice the lower limit of detection (62.5pg/ml in this case) of the IFN-γ 
ELISA. 
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2.4 Discussion 
The factors influencing the interaction between the host and the infective agent M. 
tuberculosis are hypothesized to collectively play a role in what defines latent and active 
infection. Little is known about the cytokine profile of latent infection in humans, and it 
is not yet fully understood what causes latent infection to persist in the majority of 
exposed individuals as opposed to what causes reactivation of TB disease in the minority. 
The RD1 gene region of mycobacteria has yielded valuable information about the 
different genes of interest with regard to TB research. The DosR regulon of M. 
tuberculosis is expressed in vitro under simulated in vivo conditions of nutrient 
starvation, hypoxia and low-dose NO (Voskuil M.I et al., 2003). This genomic region has 
demonstrated increasing potential in recent years, as it has been realized that proteins 
encoded by this region could provide vital information as to what constitutes protective 
immunity against TB in humans. This study evaluates the human in vitro T cell responses 
of latently infected individuals to 78 RD1 or DosR regulon encoded antigens by 
quantifying their IFN-γ production by ELISA.  
 
The results of this study have shown that all tested proteins, whether peptide or 
recombinant, were able to induce T cell responses, demonstrated by varying IFN-γ levels. 
As has been demonstrated by other studies, the IFN-γ responses to classical TB proteins 
were observed in a large number of participants (Lalvani A. et al., 2001; Weldingh K. et 
al., 2005; Porsa et al., 2006; Hoff S.T et al., 2007). An overwhelming majority of 
participants responded to ESAT-6 and TesatCFP-10, 80% and 85% respectively. 
Interestingly, other groups have found that patients with past or active TB preferentially 
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recognize these two secreted antigens over other latency antigens (Demissie A. et al., 
2006; Leyten E.M.S et al., 2006; Lin M.Y et al., 2007). This finding could suggest that a 
significant number of latently infected individuals that responded to ESAT-6 and 
TesatCFP-10 in this study could be people on the verge of progressing to active TB. It 
could also suggest that high IFN-γ responses to these antigens could be more indicative 
of latent as opposed to active infection in a South African population. TB10.4 induced 
responses in over 31% of responders, and this antigen has also been established to be 
another prime vaccine candidate (Hervas-Stubbs S. et al., 2006). There were some 
responses to proteins of the Ag85 complex (10% of responders) but responses to Ag85 
proteins fused to ESAT-6 have been shown to be stronger and more TB-specific in mice 
and macaques, indicating this protein may confer better protection as a fusion product 
than on its own (Langermans J.A.M et al., 2004; Radošević K. et al., 2007).  
 
Of the 35 latency antigens tested, 17 induced detectable responses in participants. The 
most notable 6 antigens, Rv1733c, Rv1737c, Rv1735c, Rv1736c, Rv0081 and Rv1996 
were most frequently recognized by at least 30% of responders. In addition to Rv2029c 
which was recognized by 5% of responders (not shown on figure 4), Rv1733c and 
Rv2031 have been closely associated with what may be a typical latent infection profile 
in humans and mice (Demissie A. et al., 2006; Leyten E.M.S et al., 2006; Lin M.Y et al., 
2007). The results obtained here concur with the finding that latently infected individuals 
preferentially recognize certain latency antigens over others. Rv2627c and Rv2628c have 
also been found to be strongly recognized by T cells in mice (Roupie V. et al., 2007), but 
these two antigens performed poorly in our WBA, producing responses in 0% and 5% of 
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responders respectively. New antigens that have never been tested before and have 
produced strong TB-specific IFN-γ responses here (for example Rv1737c, Rv1735c, 
Rv1736c, Rv0081 and Rv1996) show that more latency factors are at play during the 
course of dormant infection, and these proteins could be further evaluated as vaccine 
candidates. 
 
Many studies that have undertaken to test panels of TB-specific antigens for 
immunogenicity have only endeavoured to screen DosR latency or classic control, RD1-
encoded vaccine candidates. Though the production of antigens associated with 
reactivation and resuscitation has been well described, few research efforts have 
attempted to characterize the immunoreactive and vaccine properties of these proteins in 
vivo or in vitro. The present study demonstrated that 5 of the reactivation antigens 
(Rv1131, Rv1115, Rv3862c, Rv0246 and Rv0331) tested produced responses in 15% or 
more of responders and that generally, the RPFs were highly immunogenic in 
participants. One study has shown similar results in mice (Yeremeev V.V et al., 2003) 
where the capacity for RPF-like proteins to induce significantly high M. tuberculosis-
specific T cell proliferation in vivo was observed, as well as high antibody titres that 
correlated with a humoral response. It is generally accepted that a competent vaccine 
against TB would provide protection by inducing a strong cellular Th1-biased response 
(De Groot et al., 2005; Gupta D.G et al., 2007) but a humoral, immune response may also 
be of benefit. It was also observed that vaccination with RPFE or Rv2450 provided a 
significant degree of protection against TB challenge in mice, and correlated strongly 
with decreased bacterial burden in the lungs and spleen and increased survival times 
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(Yeremeev V.V et al., 2003). Although the responses to RPFs and reactivation antigens 
were merely quantitative here, there is strong supportive evidence that these proteins are 
potentially protective against reactivated TB. It would be an attractive feature for a TB 
vaccine to prime the host to recognize proteins associated with resuscitation to aid in 
combating the conversion to active disease. Including RPFs in vaccine design may be 
important for this reason.   
 
The question of the types of antigens provided was also tackled. Most (86) of the antigens 
were recombinant, E. coli vector-produced proteins whilst 10 were peptide pools. There 
was a clear difference in the level of responses to recombinant versus peptide pooled 
antigens tested at the same concentration, with the recombinant proteins inducing higher 
response levels in a markedly greater proportion of participants. Although relatively large 
amounts of protein can be generated in a bacterial construct and the production and 
purification steps can be optimized, there is the very real problem of contamination by 
vector components that can lead to high background and even false positive readouts in 
some cases. This can make the interpretation of strong positive results somewhat more 
difficult (Tom Ottenhoff at LUMC, personal communication). The obvious advantage of 
peptide pools over recombinants is the lack of vector contaminants in the protein, but 
they are more costly to make and the pooling of several peptides in a well might lead to 
interference (for example, MHC receptor site-competition) with the process of antigen 
presentation, leading to false negatives (May Young Lin and Tom Ottenhoff at LUMC, 
personal communication). Possible solutions for these problems would be additional 
purification steps, optimizing concentration dosage for recombinant proteins, and 
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minimizing the pool size and final concentration to prevent interference in the case of 
peptides. Keeping these limitations in mind, more comparisons between the two types of 
antigens need to be done to fully define and carefully interpret results. Nevertheless, 
preliminary results of large screening exercises such as the one described here provide 
important information giving valuable insight into quantitative protective immune 
responses to latent TB infection. 
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                                          CHAPTER 3 
 
Cytokine Evaluation of WBA Supernatants by Luminex Assay 
3.1 Luminex study 
3.1.1 Background 
This study was designed to complement the results generated by the conventional IFN-γ 
ELISA method used throughout the antigen screening. Although ELISA is an invaluable 
tool for measuring immune responses, it has been well recognised that IFN-γ is not the 
only cytokine generated during tuberculosis infection. In order to effectively outline an 
infection profile, a variety of other immune regulators need to be identified. Cytokine 
expression profiling (CEP) methods are relatively new immunoassay systems that have 
revolutionised the analysis of multiple cytokines in a given sample volume.  
 
These Multiplex assays like the Luminex® system employ fluorescent bead-based 
luminex technology. This immunoassay operates on the capture/detection sandwich-type 
model largely similar to the conventional ELISA method, only it has the potential to 
measure up to 100 different cytokines in a 50μl sample. This makes the system capable of 
detecting a cocktail of other analytes besides IFN-γ in culture supernatants and serum. 
These assays are thus potentially powerful methods of monitoring up- and down-
regulation of cytokines and hence providing valuable time-points of immune status. The 
time-saving advantages, ease of use, and utilisation of small volumes of often precious 
samples, makes the Luminex® technology ideal for screening purposes in large-scale 
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cross-sectional studies. The LINCO® 21-plex Human Cytokine Pre-mixed kit was used in 
this study to identify other biomarkers potentially present in human WBA supernatants. 
 
3.1.2 Experimental Design 
The setting, and participant selection and inclusion/exclusion criteria used for this study 
were identical to those used in the antigen screening study. Consent and ethical approval 
was granted by the Stellenbosch University Ethics Committee.  
 
Final Participant Cohort 
The participants used in this study were the same as in Group 2 of the antigen screening 
study, and initially consisted of 20 healthy HIV negative household contacts of newly 
diagnosed pulmonary TB cases. Five participants were excluded because their TST 
induration was later discovered to be 0mm. A posterior-anterior chest X-ray radiograph 
was also taken of all participants and none showed early signs of TB or lung disease 
development.   
 
Antigen Selection 
The scope of the experimental design for the Luminex study was restricted by the number 
of kits that were available. Experiments using the LINCO-plex assay is a costly venture, 
and the five assay kits used were kindly provided by collaborators at the Max Planck 
Institute for Infectious Biology (MPIIB). As a result, the number of antigens that could be 
tested in total was limited to 10. The 8 test conditions were chosen from a final antigen 
rank list compiled by 3 African field sites that are part of the Gates Tuberculosis 
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Consortium (GC6-74), sites that have previously screened most of the antigens 
mentioned in this body of work in other African populations. In order to complement the 
antigen screening study, the antigens were selected on the criterion that they, as a group, 
were a representative spread of most of the antigen ranks (high, intermediate and low) at 
all the sites. Table 9 shows the site and overall rankings for the chosen panel. 
 
Table 9: Field site and overall rankings for the chosen panel of Luminex antigens. This 
table is an excerpt of the rankings generated at three of the African field sites, 
Stellenbosch University (SUN, South Africa), MRC (Medical Research Council, 
Gambia) and Case (Case Western Reserve University, Uganda). The two conditions not 
shown are the negative control (RPMI-1640 with 1% glutamine) and TesatCFP-10, a 
classic vaccine antigen that performed well at all sites and was used as the positive 
control stimulant. 
Antigen 
Name 
 
SUN Rank MRC Rank CASE Rank Overall Ranking 
Rv 2450 2 1 6 1 
Rv 1733c 11 4 1 2 
Rv 1131 8 10 4 3 
Rv 0081 17 19 2 4 
Rv 1737c 6 13 8 5 
Rv 1735c 7 41 3 6 
Rv 0569c 57 48 5 19 
Rv 2029c 66 3 75 43 
 
Samples Used 
The samples used were aliquots of 7-day, antigen- stimulated WBA supernatants that had 
been previously harvested and stored at -80o C for prospective studies such as this one. 
For each participant, one 110μl aliquot of antigen-stimulated supernatant was thawed at 
http://scholar.sun.ac.za/
 55
room temperature, and then spun at 1000g for 10 minutes to sediment cellular debris 
before use. 
 
3.1.3 The LINCO® 21-plex Human Cytokine Pre-mixed kit  
This is a Multiplex assay kit that is manufactured by LINCO Research, Inc for research 
diagnostics on cell culture supernatants or serum samples. It consists of pre-mixed 
antibody-immobilised bead sets that can routinely be used for the simultaneous 
quantitative determination of human cytokines and chemokines. The kits are available as 
a 13-, 21- and 29-plex, and the methodology below describes the use of the 21-plex kit. 
The array of cytokines measured is shown below in Table 10 and Figure 8 illustrates the 
basic methodology behind the Multiplex assay. 
 
Table 10: The premix antibody-immobilised bead set for the LINCO 21-plex kit. All 
cytokines are designated a #-number for the purpose of reading the fluorescent beads 
using the multiplex software. 
21-plex Premix Beads 
#01 Human IL-1β #28 Human IL-15 
#03 Human IL-2 #30 Human IL-17 
#09 Human IL-4 #32 Human IL-1α 
#10 Human IL-5 #35 Human IFNγ 
#12 Human IL-6 #37 Human G-CSF 
#13 Human IL-7 #39 Human GM-CSF 
#20 Human IL-8 #40 Human TNFα 
#23 Human IL-10 #44 Human Eotaxin 
#25 Human IL-12p70 #46 Human MCP-1 
#26 Human IL-13 #57 Human MIP-1α 
 #65 Human IP-10 
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Figure 8: Basic methodology of the Multiplex bead-based immunoassay. Illustration 
(without annotation) appears courtesy of Bio-Rad Laboratories Inc. website, www.bio-
rad.com. 
• The technology employs the use of flourescent-dyed beads to 
which biomolecules are bound.
• Antibody specifically directed against cytokines of interest are
covalently coupled to colour-coded polystyrene beads.
• The antibody-coupled beads are allowed to react with a sample 
(supernatant) containing an unknown concentration of cytokine.
• After a series of washes to remove unbound protein, a 
biotinylated detection antibody, specific for a different epitope on 
the cytokine, is added to the beads. This results in the formation 
of a sandwich of antibodies around the cytokine.
• The reaction mixture is detected by streptavadin-phycoerythrin
(streptavadin-PE), which binds to the biotinylated detection 
antibodies.
• The well contents are drawn up into the Luminex suspension 
array system, which identifies and quantitates each specific 
reaction based on bead colour and flourescence. Unknown 
cytokine concentrations are also automatically calculated by the
system’s software.
 
 
LINCO 21-plex Assay Procedure 
The premix bead kit was used as per the manufacturer’s instructions with a few 
alterations. Briefly, culture supernatants were thawed and spun down at 1500rpm for 10 
minutes to precipitate cellular debris. To generate a 5-point standard curve, the 
reconstituted cytokine standard cocktail was serially diluting into 2000, 400, 80, 16, and 
3.2pg/ml concentrations. For the quality controls, the two control buffers (QC-I and QC-
II) were used as directed by the kit. In addition, 25μl of control buffers was also added to 
aliquots of the sample supernatants (supernatant stimulated for 7 days with the chosen 
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antigens and pooled) and these were used as spiked controls. The filter plate was blocked 
with 200μl of assay buffer, left at RT on a standard plate shaker for 10 minutes. The 
buffer was then removed by vacuum aspiration and 25μl of assay diluent was added to 
sample wells whilst RPMI-1640 with 1% glutamine was added to standard wells. 
Following the suggested vertical sample placement on the plate layout, 25μl of either 
standard, control, spiked control or neat supernatant solution was added to the appropriate 
wells, followed by the addition of 25μl antibody-coated fluorescent beads. After 1-hour 
incubation on a plate shaker at RT, the fluid was gently aspirated. Biotinylated secondary 
antibody was then added, followed by streptavidin- labelled phycoerythrin antibody, with 
alternate washing and incubation steps between addition of each antibody. Finally, 100μl 
of sheath fluid was put into each well and the beads were resuspended gently for 5 
minutes, after which the plate was read on the Bio-plex® array reader. Plates were read at 
high and low RP1 target to generate broad range and high sensitivity plots. Preliminary 
data analysis was done using the Bio-Plex Manager software (Bio-Rad Laboratories) with 
a five-parametric regression curve (5-PL) fitting. 
 
Assay Characteristics and Standard definitions 
Reading: The reported fluorescence of the sample/well measured in pg/ml. All readings 
higher than the observed background sample reading are taken as positive. 
 
Recovery: This is the ratio of the observed (actual reading) over the expected 
(manufacturer’s guideline) concentration in a sample, expressed as a percentage. 
Recoveries falling in the range of 70 - 130% are considered acceptable for this assay. 
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Sensitivity: The minimum detectable concentrations of each evaluated cytokine in pg/ml, 
depending on the amount of time lapsed immediately after when the plate should be read. 
The sensitivity is determined by two sets of standard curve ranges, the broad (1.95 – 32 
000 pg/ml) and the high sensitivity (0.2 - 3.2pg/ml). 
 
Linearity: This ratio describes the observed amount of cytokine in a sample as compared 
to the observed total amount of cytokine in an undiluted sample of the same type. This 
ratio is multiplied by the coefficient of dilution and expressed as a percentage. 
 
RP1: The RP1 is the channel through which the fluorescent beads flow for quantitation 
on the assay reader. Low RP1 is the fluorescent channel recommended to assay a wide 
range of cytokine concentrations or when the range of expected concentrations is 
unknown. Hence, low RP1 gives rise usually to a broad range standard curve. High RP1 
conversely is ideal for quantifying low cytokine levels and provides for greater assay 
sensitivity, and therefore makes use of the high sensitivity standard curve. 
 
3.2 Statistical Analysis 
Box plots were used to visually display log expressions for different cytokines and 
antigens.  A factor analysis was done to determine the factor structure underlying all the 
cytokine variables.  The scree plot was used to determine the number of factors, and 
factor loadings were calculated using the varimax rotation. 
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3.3 Results 
3.3.1 Quality Control Assessment 
The quality control (QC) evaluation is carried out as a standard procedure during the 
course of the run for each LINCO-plex plate, to validate that the run was successful and 
any large variations in the results was not due to defects in the kit. The two supplied 
controls are premixed, lyophilized human cytokine cocktails called QC-I and QC-II. Each 
analyte of the 21-plex assay is expected to produce a read-out that lies within a range for 
both controls. Figures 9 and 10 are graphical representations of expected and observed 
outcomes for QC-I and QC-II. In addition, the control buffers were spiked with 
participant supernatant and the effects of the spiked controls, QC-I-sup and QC-II-sup, 
are also shown in Figures 11 and 12. 
 
Results of Kit Validation and Quality Control (QC) 
Generally, the outcome of the validation and the QC evaluation revealed that the analytes 
performed at acceptable levels and the supplied kit was in good working condition. 
Recoveries for all the 21 cytokines were within the 70 – 130% acceptable range. All 
observed values for QC-I fell within the expected ranges for each cytokine, as well as for 
QC-II, with the exception of 5 cytokines for the latter. Of the 5 observed out-of-range 
values for QC-II, only MCP-1 was of significant concern, yielding a result of 2600pg/ml 
which was extremely high (figure 10). The observed values for the other four cytokines, 
IL-2, IL-5, IL-8 and MIP1-α, only exceeded their expected ranges by an average of about 
100pg/ml (figure 10).  
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When the QC buffers were spiked with human supernatant to test its effect on their 
performance, it was also shown that in general, the addition of supernatant did not affect 
the QC expected value. For QC-I, the most notable difference was that the added sample 
appeared to lower the action of the buffer to below what was expected. This was 
observed for 9 out of the 21 cytokines, but only 5 of the 9 (IL-6, IL-8, MCP-1, MIP1-α 
and IP-10) showed a considerable decrease (figure 11). QC-II spiked with supernatant 
showed that two cytokines, IL-8 and MCP-1, fell considerably out of their expected 
ranges by about 400pg/ml (figure 12).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
http://scholar.sun.ac.za/
 61
Figure 9: Quality control assessment of each analyte of the LINCO 21-plex using QC-I. 
The upper and lower bars of the concentration range denote the highest and lowest 
expected values, and the open circle indicates where the observed value fell for each 
analyte.  
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Figure 10: Quality control assessment of each analyte of the LINCO 21-plex using QC-II. 
The upper and lower bars of the concentration range denote the highest and lowest 
expected values, and the open circle indicates where the observed value fell for each 
analyte.  
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Figures 11 and 12: Quality control assessment of each analyte of the LINCO 21-plex, 
using supernatant-spiked controls, QC-I-sup and QC-II-sup respectively. The upper and 
lower bars of the concentration range denote the highest and lowest expected values, and 
the open circle indicates where the observed value fell for each analyte.  
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3.3.2 Evaluation of the Assay by Antigen 
Negative Control 
To standardize the LINCO-plex assay with the ELISA, RPMI with 1% glutamine, which 
was used as the negative control in the 6-day whole blood assay, was also used here as 
the unstimulated control. As expected, most of the cytokines showed a very low response 
to the unstimulated control, with values in the range of 2 – 10pg/ml (figure 13). Two 
cytokines, IL-8 and MCP-1, showed unexpectedly higher responses to the negative 
control, each with a median value of about 50pg/ml. 
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Figure 13: Box plot of the negative control condition using the LINCO 21-plex assay. 7-day 
WBA supernatant stimulated with ten “antigen” conditions were tested against an array of 21 
cytokines. The sample participant group (n=15) consisted of TST-positive, HIV-negative 
Household contacts. The upper and lower limits of the box denote the 25 – 75percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open circles 
and asterisks indicate outliers and extremes. 
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TesatCFP-10 
The fusion protein of ESAT-6 and CFP-10, TesatCFP-10, was used as the positive 
control stimulant. Most of the cytokines responded favourably to the positive control. 
Lower median values were around 30 – 75pg/ml for IL-1B, IL-2, IL-5, IL-10, IL-13, IL-
17, IL-4, G-CSF, IL-1α and eotaxin (figure 14). Moderately high median values were 
recorded for TNF- α (200pg/ml), GM-CSF (500pg/ml), and MIP-1α (500pg/ml). Higher 
concentrations, above 1000pg/ml, were observed for IL-6, IL-8, IFN-γ, MCP-1 and IP-
10. IL-4, IL-15 and IL-12p70 produced no responses to the positive control. 
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Figure 14: Box plot of the positive control condition TesatCFP-10, using the LINCO 21-plex 
assay. 7-day WBA supernatants stimulated with ten “antigen” conditions were tested against an 
array of 21 cytokines. The sample participant group (n=15) consisted of TST- positive, HIV-
negative Household contacts. The upper and lower limits of the box denote the 25 – 75percentile 
and the whisker lines denote the non-outlier range. Open squares denote the medians, and open 
circles and asterisks indicate outliers and extremes. 
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Rv2450 
Most of the cytokine responses to Rv2450 were low to moderately high, ranging from 50 
– 250pg/ml (figure 15). High median responses to the antigen were produced by IL-6 
(over 1000 pg/ml), MCP-1 (5000 pg/ml) and IL-8 (about 10 000pg/ml). Seven cytokines 
(IL-2, IL-4, IL-5, IL-7, IL-13, IL-15 and IL-12p70) showed no reaction to Rv2450. 
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Figure 15: Box plot of antigen Rv2450 using the LINCO 21-plex assay. 7-day WBA supernatants 
stimulated with ten “antigen” conditions were tested against an array of 21 cytokines. The sample 
partcipant group (n=15) consisted of TST positive, HIV negative Household contacts. The upper 
and lower limits of the box denote the 25 – 75percentile and the whisker lines denote the non-
outlier range. Open squares denote the medians, and open circles and asterisks indicate outliers 
and extremes. 
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Rv1733c 
Generally, median concentration responses to Rv1733c were moderately high, ranging 
from 100 – 600pg/ml on average (figure 16). High median readouts above 5000pg/ml 
were observed for IL-6, IL-8 and MCP-1. IL-2, IL-4, IL-5, IL-7, IL-13, IL-15, IL-17 and 
eotaxin were not produced in response to Rv1733c. 
 
 
 
Rv1733c
IL
-1
B 
(1
)
IL
-6
 (1
2)
IL
-8
 (2
0)
IL
-1
0 
(2
3)
IL
-1
al
ph
a 
(3
2)
G
-C
S
F 
(3
7)
TN
F-
al
ph
a 
(4
0)
M
C
P
-1
 (4
6)
M
IP
-1
al
ph
a 
(5
7)
IP
-1
0 
(6
5)
IF
N
-g
am
m
a 
(3
5)
G
M
-C
S
F 
(3
9)
IL
-1
2p
70
 (2
5)
Cytokine
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
Lo
g 
ex
pr
es
si
on
 o
f C
on
ce
nt
ra
tio
n 
(p
g/
m
l)
 
 
 
 
 
 
 
 
Figure 16: Box plot of antigen Rv1733c using the LINCO 21-plex assay. 7-day WBA 
supernatants stimulated with ten “antigen” conditions were tested against an array of 21 
cytokines. The sample participant group (n=15) consisted of TST positive, HIV negative 
Household contacts. The upper and lower limits of the box denote the 25 – 75percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open circles 
and asterisks indicate outliers and extremes. 
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Rv 1131 
Lower cytokine responses were produced to Rv1131 (figure 17). With the exception of 
IL-6, IL-8 and MCP-1 which produced responses between 500 – 5000pg/ml, most of the 
other cytokines trailed behind with low values in the range of 10 – 100pg/ml. Only one 
participant produced low levels of GM-CSF, IL-1B and G-CSF (not the same participant 
for each cytokine). Eight cytokines were not produced following stimulation with 
Rv1131. 
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Figure 17: Box plot of antigen Rv1131 using the LINCO 21-plex assay. 7-day WBA supernatants 
stimulated with ten “antigen” conditions were tested against an array of 21 cytokines. The sample 
participant group (n=15) consisted of TST positive, HIV negative Household contacts. The upper 
and lower limits of the box denote the 25 – 75percentile and the whisker lines denote the non-
outlier range. Open squares denote the medians, and open circles and asterisks indicate outliers 
and extremes. 
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Rv0081 
Of the 21 cytokines in the assay, only 7 were produced after stimulation with Rv0081 
(figure 18). IL-1α, TNF- α, MIP-1α, IL-6 and IL-8 were produced in low levels, in the 
range of 10 – 70pg/ml. Higher quantities of IL-8 and MCP-1 (about 500p/ml) were 
produced. 
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Figure 18: Box plot of antigen Rv0081 using the LINCO 21-plex assay. 7-day WBA supernatants 
stimulated with ten “antigen” conditions were tested against an array of 21 cytokines. The sample 
participant group (n=15) consisted of TST positive, HIV negative Household contacts. The upper 
and lower limits of the box denote the 25 – 75percentile and the whisker lines denote the non-
outlier range. Open squares denote the medians, and open circles and asterisks indicate outliers 
and extremes. 
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Rv 1737c 
The median cytokine levels to Rv1737 were mostly in the low to moderate range of 
25pg/ml (GM-CSF) to 300pg/ml (IP-10). Again, IL-6, IL-8 and MCP-1 were generated in 
high levels, above 5000pg/ml (figure 19). 
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Figure 19: Box plot of antigen Rv1737c using the LINCO 21-plex assay. 7-day WBA 
supernatants stimulated with ten “antigen” conditions were tested against an array of 21 
cytokines. The sample participant group (n=15) consisted of TST positive, HIV negative 
Household contacts. The upper and lower limits of the box denote the 25 – 75percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open circles 
and asterisks indicate outliers and extremes. 
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Rv1735c 
Most cytokines expressed at low to moderate levels after stimulation with Rv1735c 
(figure 20). Concentrations were in the range of 20 – 80pg/ml for nine of the thirteen 
cytokines expressed, and IP-10 showed more moderate-to-high level expression at about 
200pg/ml. High level cytokine expression was observed for IL-6, IL-8 and MCP-1 (about 
4000 – 9000pg/ml).  
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Figure 20: Box plot of antigen Rv1735c using the LINCO 21-plex assay. 7-day WBA 
supernatants stimulated with ten “antigen” conditions were tested against an array of 21 
cytokines. The sample participant group (n=15) consisted of TST positive, HIV negative 
Household contacts. The upper and lower limits of the box denote the 25 – 75percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open circles 
and asterisks indicate outliers and extremes. 
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Rv0569c 
IL-1B, IL-10, IFN-γ, GM-CSF, MIP-1α and G-CSF were produced at low levels of 
between 10 – 70pg/ml (figure 21). IL-1α and TNF-α were expressed at moderately high 
levels (at or slightly above 100pg/ml) and the high-level expressors were IL-6, IL-8 and 
MCP-1 (above 5000pg/ml). Eotaxin, IL-17 and IL-4 performed poorly, each showing a 
weak reaction in only one participant.  
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Figure 21: Box plot of antigen Rv0569c using the LINCO 21-plex assay. 7-day WBA 
supernatants stimulated with ten “antigen” conditions were tested against an array of 21 
cytokines. The sample participant group (n=15) consisted of TST positive, HIV negative 
Household contacts. The upper and lower limits of the box denote the 25 – 75percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open circles 
and asterisks indicate outliers and extremes. 
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Rv 2029c 
Low-level expression cytokines for Rv2029c were IL-1B, IL-10, IL-1α, GM-CSF, IL-17, 
MIP-1α and G-CSF, in the range of 20 – 100pg/ml (figure 22). Moderately high levels of 
IFN-γ and IP-10 (400 – 600pg/ml) and high to very high levels of IL-6, IL-8 and MCP-1 
(2000 – 8000pg/ml) were recorded. 
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Figure 22: Box plot of antigen Rv2029c using the LINCO 21-plex assay. 7-day WBA 
supernatants stimulated with ten “antigen” conditions were tested against an array of 21 
cytokines. The sample participant group (n=15) consisted of TST positive, HIV negative 
Household contacts. The upper and lower limits of the box denote the 25 – 75percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open circles 
and asterisks indicate outliers and extremes. 
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3.3.3 Evaluation of the Lincoplex Assay by Cytokine 
For ease of evaluation, the performance of each cytokine after stimulation with the ten 
conditions was grouped according to their levels of expression. As shown on the previous 
graphs, the upper and lower limits of the box denote the 25 – 75 percentile and the 
whisker lines denote the non-outlier range. Open squares denote the medians, and open 
circles and asterisks indicate outliers and extremes. 
 
 
High to Very High-Level Expression Cytokines 
Figures 23, 24 and 25 show the 3 cytokines, IL-6, IL-8 and MCP-1, that consistently 
expressed at the highest levels after stimulation with the nine antigen conditions 
(excluding the negative control). TesatCFP-10, the positive control, induced high 
cytokine levels (about 3000- 9000pg/ml) of all three cytokines. Antigen Rv0081 overall 
induced the lowest cytokine levels, with median values for all 3 cytokines ranging from 
50 – 500pg/ml, followed by Rv1131 which was lower in IL-6 (median of 500pg/ml) and 
IL-8 (median of 1000pg/ml). The other 7 antigens produced similar cytokine levels, 
producing median readouts of about 3000pg/ml for IL-6 and above 5000pg/ml for both 
IL-8 and MCP-1.  
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Figures 23 - 25: Box plots of IL-6, IL-8 and MCP-1 expression levels using the LINCO 21-plex 
assay. 7-day WBA supernatants stimulated with ten “antigen” conditions were tested against an 
array of 21 cytokines. The sample participant group (n=15) consisted of TST-positive, HIV-
negative Household contacts. 
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Moderately High-Level Expression Cytokines  
Figures 26 – 33 show the 8 cytokines (IL-1α, G-CSF, IP-10, MIP-1α, INF-γ, TNF-α, IL-
1B and IL-10) that were induced at moderate levels after stimulation with the nine 
antigen conditions. TesatCFP-10 positively induced cytokine expression of all the 8 
cytokines, at lower levels for IL-1α, G-CSF, TNF-α, IL-1B and IL-10 with median values 
of 20 – 100pg/ml, and at higher levels for IP-10, MIP-1α and INF-γ with median values 
of 500 – 3000pg/ml. Rv1733c induced, on average, higher cytokine levels than the other 
7 non-control antigens, its induction level of IL-1α, MIP-1α, TNF-α, IL-1B and IL-10 
being significantly higher than levels of the same cytokines for the other antigens. 
Rv2450c, Rv1737c, Rv1735c, Rv0569 and Rv2029c stimulated similar patterns of 
cytokine production, with median value ranges of 30 – 200pg/ml for each cytokine. 
Again, Rv0081 and Rv2450 were low cytokine stimulators, showing little or no induction 
of cytokine expression across the board. 
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Figures 26 - 29: Box plots of IL-1α, G-CSF, IP-10 and MIP-1α expression levels using the 
LINCO 21-plex assay. 7-day WBA supernatants stimulated with ten “antigen” conditions were 
tested against an array of 21 cytokines. The sample participant group (n=15) consisted of TST-
positive, HIV-negative Household contacts.  
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Figures 30 - 33: Box plots of INF-γ, TNF-α, IL-1B and IL-10 expression levels using the LINCO 
21-plex assay. 7-day WBA supernatants stimulated with ten “antigen” conditions were tested 
against an array of 21 cytokines. The sample participant group (n=15) consisted of TST-positive, 
HIV-negative Household contacts.  
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Low-Level Expression Cytokines 
Figures 34 and 35 are of IL-17 and GM-CSF, the two analytes that were expressed at 
very low levels, or not at all for some antigens, during the experiment. With the notable 
exception of TesatCFP-10 which induced relatively high levels of GM-CSF, median 
values for both cytokines trailed in the 10 – 40pg/ml range. 
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Figures 34 and 35: Box plots of IL-17 and GM-CSF expression levels using the LINCO 21-plex 
assay. 7-day WBA supernatants stimulated with ten “antigen” conditions were tested against an 
array of 21 cytokines. The sample participant group (n=15) consisted of TST positive, HIV 
negative Household contacts.  
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No Cytokine Expression except for in TesatCFP-10 
Following stimulation, IL-2, IL-4, IL-5, IL-13, IL-12p70 and eotaxin were either 
expressed at very low levels or not at all for any of the antigens except for TesatCFP-10 
(data not shown here). The positive control itself was only able to induce sporadic 
expression in few or single participants at a time, with levels reaching only 20pg/ml. 
 
No Cytokine Expression at all 
Throughout the experiment, IL-7 and IL-15 expression was nil for all antigen conditions, 
including the negative and positive controls (data not shown here). 
 
Comparison of the ELISA and Luminex methods 
A final correlation between the two assays performed for the antigen screening (ELISA) 
and the multiplex cytokine assay (Luminex) was done where the assays were statistically 
compared. Using only the IFN-γ data, which was the shared readout value of both 
techniques, intra-class correlation (ICC) co-efficients were generated between the assays, 
displayed in Table 10 below. It was demonstrated that though there was only some 
agreement and consistency between how the different antigens fared within each 
technique, overall there was a strong positive correlation between the performance of the 
two assays. 
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Table 10: Intra-class correlation co-efficients between the two cytokine assays, Luminex 
and ELISA. Only results generated from IFN-γ expression was used for the correlation. 
The two-way ICC was calculated where all subjects were statistically rated by the same 
judges. 
 Rater 1 Rater 2 ICC Agreement ICC Consistency 
TesatCFP10 Luminex ELISA 0.56 0.64 
Rv2450 Luminex ELISA 0.25 0.41 
Rv1733c Luminex ELISA 0.4 0.58 
Rv1131 Luminex ELISA 0.24 0.36 
Rv0081 Luminex ELISA -6.26 -6.59 
Rv1737c Luminex ELISA 0.45 0.66 
Rv1735c Luminex ELISA 0.34 0.53 
Rv0569 Luminex ELISA 0.55 0.67 
Rv2029c Luminex ELISA 0.95 0.97 
Overall Luminex ELISA 0.75 0.77 
 
 
3.3.4 Factor Analysis, Eigenvalues and Factor Loadings  
A factor analysis is a statistical undertaking that is performed when a large amount of 
data, or set of variables, has been analysed, and endeavours to explain the data in a 
competent, and this case biologically relevant, manner. The purpose of the analysis is to 
put the variables into groups called factors, and ascertain if how they interact within these 
factors can explain a significant portion of the data set. Factor loadings describe how the 
original variables, cytokines in this case, load or correlate to the ascribed factors. The 
STATISTICA software programme was used here to arrive at a factor analysis for the 
Luminex data. 
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Scree Plot 
A scree plot is drawn to first reduce the many variables into a few factor categories to 
examine their combined effect within that factor category, and then examine how many 
factors affect the whole data set. The scree plot therefore takes into account how many of 
the factors, as a composite, reliably explains most of the data. The first factor, or 
eigenvalue, has the most weight and therefore should account for most of the relevance of 
the experiment. All subsequent factors/eigenvalues have decreasing significance and 
explain less of the data, with the last value having the least impact. The size of the 
eigenvalue means how much variance in the data is explained by a specific 
factor/eigenvalue, and the first factor usually has the largest size, followed by the second 
factor, etc. Figure 36 below shows the scree plot that was constructed for the Luminex 
analysis, and Tables 11 and 12 show how many factors were considered to explain the 
greatest portion of the data, and the factor loadings. 
 
3.5.4.1 Results of the Factor Analysis 
It was shown that the first 4 factors accounted for most of the data (72%), and the rest of 
the eigenvalues thereafter had low or negligible significance. Taken alone, factor 1 
(which loaded 7 cytokines) accounted for about 35% of the variance, factor 2 (8 
cytokines) for 20%, factor 3 (3 cytokines) for 11% and factor 4 (2 cytokines) for 6%.  
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Figure 36: Scree Plot of Eigenvalues for the Luminex study. The total number of 
eigenvalues considered relevant for this study is shown on the x-axis, and the size of 
eigenvalues on the y-axis shows how much variance is explained by each factor. 
STATISTICA™ was used to construct this graph. 
 
 
Table 11: Factor analysis for the Luminex study. The 21 cytokines loaded on the first 4 
factors, which were considered the most important as they explained a cumulative 
71.85% of the data. 
Factor Size of Eigenvalue % Total Variance Cumulative Eigenvalue Cumulative % 
1 7.29 34.69 7.29 34.70 
2 4.14 19.69 11.42 54.40 
3 2.33 11.09 13.75 65.50 
4 1.34 6.36 15.09 71.85 
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Table 12: Factor loadings for the Luminex assay. The factor loading was varimax 
normalized, and all marked loadings are > 0.600. Cytokines marked in red loaded on 
factor 1, yellow in factor 2, blue on factor 3 and green on factor 4. Marked in pink is one 
cytokine, IL-17, which did associate with a factor (0.508) but not as strongly as other 
cytokines. 
 
 
Factor Loadings (Varimax normalized) (Marked loadings are >0.70) 
Variable (cytokine) Factor 1 Factor 2 Factor 3 Factor 4 
IL-1B (1) 0.899 0.169 -0.170 0.126 
IL-2 (3) 0.022 0.699 0.327 0.083 
IL-4 (9) 0.099 0.720 0.288 0.011 
IL-5 (10) -0.016 0.868 0.264 0.040 
IL-6 (12) 0.859 0.142 -0.068 0.259 
IL-7 (13) 0.317 0.716 -0.048 0.110 
IL-8 (20) 0.506 -0.008 0.047 0.751 
IL-10 (23) 0.675 0.004 0.221 0.030 
IL-12p70 (25) 0.353 0.734 -0.254 -0.156 
IL-13 (26) -0.058 0.661 0.472 0.196 
IL-15 (28) -0.082 0.743 -0.107 -0.406 
IL-17 (30) -0.053 0.508 0.266 0.397 
IL-1alpha (32) 0.890 0.066 0.177 0.249 
IFN-gamma (35) 0.319 0.046 0.843 -0.047 
G-CSF (37) 0.885 0.023 0.063 -0.001 
GM-CSF (39) 0.181 0.300 0.899 0.103 
TNF-alpha (40) 0.835 0.232 0.250 0.256 
Eotaxin (44) 0.086 0.623 0.077 0.057 
MCP-1 (46) 0.243 0.040 0.034 0.815 
MIP-1alpha (57) 0.618 -0.009 0.313 0.018 
IP-10 (65) 0.064 0.232 0.830 0.088 
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3.4 Discussion 
Scientific research has greatly expanded our knowledge of the functions, complexity and 
synergy of cytokines in immune profiling, and great strides have also been taken with 
associated technology to keep pace with these advances. The Luminex multi-analyte 
profiling system (Lab-MAP) has proven to be of extensive use in the simultaneous 
detection of an array of cytokines present in body fluids like serum and supernatant, and 
the clinical applications of this technology are manifold. One of the first studies to 
validate this new generation of cytokine assay was conducted in 1998 by researchers 
from the Luminex Corporation, who set out to measure four cytokines in human cell 
culture supernatants and compare the assay to a standard ELISA (Oliver K.G et al., 
1998). Subsequent studies also went on to give credence to bead-based multiplex assays, 
detecting a cocktail of cytokines in serum and PBMCs of mice and humans (Carson R.T 
and Vignali D.A, 1999; Kellar K.L et al., 2001; Prabhakar U. et al., 2002). This study 
reports on the Luminex bead assay being used to detect cytokines in antigen-stimulated 
human culture supernatants. The results show this assay produces results with a much 
wider scope than a conventional single-cyokine ELISA, and it also has high sensitivity 
and accuracy. 
 
In this study, a pre-mixed Luminex kit for quantitating 21 human cytokines in culture 
supernatants was evaluated and essentially yielded very comparable results to a standard 
IFN-γ ELISA. The recoveries of each cytokine was found to be well within the 
acceptable range of 70 – 130%, and the quality control and spiking experiments deemed 
the assay fit for cytokine quantification. Although the spiking experiments of the quality 
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control did show that the addition of supernatant to the QC buffers did have a tendency to 
throw the observed value outside of the acceptable range, in general this did not indicate 
that the quality of supernatant would adversely affect the performance of most cytokines 
during the experiment.  
 
The panel of 21 cytokines was varied in scope in terms of covering the range of analytes 
thought to play a role in human immune responses, and they were representative of non-
specific, as well as Th1 and Th2-associated mediators. The result of the factor analysis 
showed that the tone of the response observed here was largely a Th1-biased one, based 
on the associated cytokines that explained 47% of the data (combination of cytokines 
loading on factor 1 and 3). IFN-γ, TNF-α, IP-10, MIP1-α and G-CSF were all Th1-biased 
cytokines inducers that expressed at encouraging levels after stimulation with the 
antigens, especially TesatCFP10. The induction of the pro-inflammatory cytokines IFN-γ 
and TNF-α gives credence to the view that the immune profile after mycobacterial 
infection is a primarily a cytotoxic T cell-mediated one generated in response to an 
intracellular pathogen, a response which stimulates the activation of macrophages, 
lymphocytes and NK cells (Flynn J.L and Chan J., 2001, Kaufmann S.H.E et al, 2006).  
 
MIP1-α, IP-10 and G-CSF are also chemoattractants that play a role in the CMI response, 
by inducing directed chemotaxis in nearby responsive cells and attracting them to the site 
of infection. After exposure to M. tuberculosis, these chemokines are produced largely by 
T cells. They have the effect of increasing the production, differentiation and clonal 
expansion of phagocytic macrophages, NK cells and dendritic cells, all of which are 
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important in phagocytosis, bacterial killing and antigen presentation via the MHC I and II 
pathways. IL1-1α and IL-1B tend to be classified as non-specific or pleiotropic cytokines, 
as they are readily produced by and have effects on a variety of cells in the body, and 
their induction here could well be associated with that of the Th1 cytokines. IL-10 is an 
anti-inflammatory mediator that suppresses IFN-γ production and thus represses the pro-
inflammatory response (Raja A., 2004). It is an important mediator in controlling what 
would otherwise be a hyperactive and ultimately destructive expression of Th1 cytokines 
like IL-12 and IFN-γ, and its detection here may suggest that its presence is necessary for 
the modulation of the protective response after mycobacterial infection.  
 
The failure to see a strong induction of IL-2, IL-15 and IL-12p70, which loaded with 
other low expressors onto factor 2, could be explained by the fact that these cytokines, 
particularly IL-2, are early postexposure Th1 cytokines. IL-2 and IL-12p70 (like IL-12) 
are key players in the differentiation and proliferation of CD8 and CD4 T cells 
respectively, and IL-15 has similar functions to IL-2 (Ladel C.H et al., 1997; Blanchard 
D.K et al., 1989). They were not measured in generous quantities in this case because 
their production had probably peaked and then tailed off by the end of the 7-day WBA, 
rendering them practically undetectable. It is also likely that these cytokines were 
degraded over time by proteases in the supernatant, or that receptor-bound cytokine was 
spun out of the supernatant when protein debris was removed by centrifugation. A shorter 
time course experiment to measure when levels of these cytokines are optimal would 
most likely reveal they are present in appreciable amounts in the first 1 – 3 days of the 
assay.  
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Following antigen stimulation, IL-7, IL-4, IL-5, IL-13 and eotaxin were very poorly 
expressed across the board, being produced only in very low levels in a few cases 
following stimulation with TesatCFP10. IL-7 encourages the differentiation of naïve B 
and T progenitors to differentiate into mature immune cells, and its absence may be 
indicative that either it was not detected because it is an early-induced molecule like IL-2 
or that it is not necessary as a regulator during infection with M. tuberculosis. IL-4, IL-5, 
IL-13 and eotaxin are well-defined Th2 regulators, and early production of IL-4 
particularly favours the proliferation of B cells, mast cells and eosinophils, and 
subsequent antibody production. The clear failure to detect any contributing Th2 cytokine 
in this evaluation lends further support to the theory that the Th1 response predominates 
during mycobacterial infection and confers immune protection (Flynn J.L et al., 1993; 
Lin Y. et al., 1996; Cooper A.M et al., 1997), but sheds no light as to how the Th2 
response can contribute protection against disease. The characterisation of this aspect of 
TB immunity requires further elucidation. 
 
IL-6, IL-8 and MCP-1 showed a tendency to express at levels 2- to 3-log higher than the 
other cytokines. The pattern of expression of these three Th2 cytokines was somewhat 
unexpected and discordant from what was expected: surprising, in that these Th2 
cytokines unfailingly expressed at remarkably high levels after antigen stimulation when 
a clear Th1 profile was anticipated, and discordant in that their magnitude of expression 
also did not correlate with the low levels of their other Th2-associated counterparts. 
Although IL-6 has been established as a Th2 cytokine closely linked to B cell activation 
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and antibody production, it also activates T cells and stimulates the production of acute 
phase proteins and IFN-γ, thus contributing to the inflammation that is characteristic of 
early infections (VanHeyningen T.K et al., 1997; Saunders B.M et al., 2000). It is 
therefore understandable to see this cytokine’s expression linked to that of the Th1/factor 
1 components. IL-8 and MCP-1 act as chemoattractants after infection, activating and 
mobilizing neutrophils, monocytes and lymphocytes; IL-8 prompting neutrophils and 
naïve T cells and MCP-1 guiding monocytes to leave the bloodstream and migrate to 
surrounding tissues. The action of the two cytokines is also usually accompanied by acute 
inflammation, which can occur during both Th1 and Th2-biased infections, which would 
explain why they were still measured in large quantities in the Luminex assay. The action 
of these two cytokines is also strongly complementary in vivo, and the findings here 
support their syngergistic effects (both cytokines loaded strongly on factor 4, which 
accounted for 6% of data variance). A high level of IL-6, IL-8 and MCP-1 in the 
supernatants is also indicative of the presence of bacterial endotoxins. Antigens produced 
in bacterial vectors, as the recombinant antigens tested here were, are known to contain 
appreciable quantities of endotoxins. Lipopolysaccharide (LPS), a cell wall component of 
other non-tuberculous bacteria like Escherichia coli, has been known to over-stimulate 
the production of a distinct group of cytokines and chemokines, of which IL-6, IL-8 and 
MCP-1 are a part (Zhang Y. et al., 1994; Christodoulides M. et al., 2002). Mycobacteria 
also contain a glycolipid called lipoarabinomannan (LAM), which is functionally similar 
to LPS. It is difficult to distinguish whether the high productionof these 3 immune factors 
here is specific to M. tuberculosis or indicates antigenic contamination with interfering 
bacterial-vector components. 
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This study has produced multiplex results for TB-specific antigens that correlate well 
with what was found in the antigen screening study, as well as what has been found when 
similar screening studies have been undertaken worldwide. It has been shown here that 
the fusion product of ESAT-6 and CFP10 (TesatCFP10), which has long been recognized 
as a classic TB antigen, is strongly immunogenic in people infected with latent 
tuberculosis and living in an area of high TB incidence. This finding corroborates those 
of other groups that also demonstrated that significant antibody responses to ESAT-6, 
CFP10 and the fusion protein are consistent with latent infection as well as active disease 
(Weldingh K. et al., 2005; Porsa et al., 2006; Hoff S.T et al., 2007). This antigen appears 
to be very important for use in new serodiagnostic assays and vaccines being developed 
against TB, as it is now generally recognized that latently infected individuals are 
strongly positive for ESAT-6 and CFP10 in both antibody- and CMI-based assays 
(Lalvani A. et al., 2001; Hoff S.T et al., 2007). Three other antigens that were well-
recognised and induced significant cytokine levels were Rv1733c, Rv0569 and Rv2029c. 
These latency antigens have also been found to be frequently recognized as TB-specific 
in the sera and supernatant of latently and active infected TB patients (Leyten E.M.S et 
al., 2006; Lin M.Y et al., 2007).  
 
The Luminex study has shown the multiplex assay to not only be highly comparable to 
the ELISA ‘gold standard’ method of cytokine detection, but also accurate and 
reproducible. This fluorescent bead-based technique has the obvious advantage of being 
able to detect multiple analytes in a single sample, and the aliquot size needed for a single 
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run can be up to an eighth of the volume required to run an ELISA sample in duplicate. 
One limiting feature of the multiplex assay is the mixing and quantification of multiple 
analytes in a single well. Cross-reactivity between receptors and non- or less-specific 
molecules can result in false positive readings, whilst interference from other blocking 
antibodies or contaminating proteins can result in false negatives (de Jager W. and 
Rijkers G.T, 2006). Optimisation of the assay can overcome these issues, and the 
increasing popularity of multiplex immunoassays marks a trend to integrate their use in 
more research and clinical diagnostic studies such as this one. 
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                                                CHAPTER 4 
General Discussion and Conclusion 
The rate of infection with tuberculosis has reached pandemic proportins worldwide, and 
our current methods of diagnosing the disease are not highly specific or effective. One 
critical step to curbing the spread of TB would be the development of an effective 
method to diagnose latent tuberculosis in the early post-exposure phase. For over 100 
years, TB infection has been detected using the tuberculin skin test, but issues of cross-
reactivity with non-tuberculous mycobacteria, errors in administering the intradermal 
injection and anergy in immunosuppressed individuals have negatively affected the 
reliability of the test (Desem N. and Jones S.L, 1998). Many TB diagnostic assays also 
rely heavily on the production of IFN-γ to measure the level of response in affected 
people, but it has been established that other immune mediators play a significant role in 
characterizing the natural protective immune response to TB. There is therefore urgent 
need not only for other immune correlates of protection to be identified in humans, but 
also for tools and assays that would enable the immune profile to be well characterized to 
be developed and optimized. 
 
This study has demonstrated that a novel panel of MTB-specific antigens screened in a 
population with a high incidence of latent TB infection could produce detectable cytokine 
responses, not just of IFN-γ but a host of other cytokines and chemokines. The antigen 
screening project was a relatively large-scale endeavour, and to my knowledge, covered 
the largest and widest range of MTB-specific antigens that has been screened in an 
African population. There were a few interesting aspects of the study that were not fully 
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addressed, such as the correlation of the responses with TST induration or gradient of 
exposure. The profile of the responses seen here would also be interesting after 
participants were followed up at certain time-points over a longer period, to see how 
many progressed to active disease and how many did not, and how this correlated with 
their . Nevertheless, the results generated here represent a useful and novel 
characterization profile of the immune response to tuberculosis. It has been shown that 
IFN-γ is an important correlate produced after exposure to TB, as are many other 
cytokines. It has also been shown that the Multiplex assay is a simple, sensitive and 
versatile method that could be valuable as a prognostic tool in outlining the course of 
infection with M. tuberculosis. 
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